











Submitted in partial fulfillment of 
the requirements for the degree of 
Doctor of Philosophy 

























All rights reserved  
ABSTRACT 
Engineering the cell environment for meniscus repair: from micro- to macro-scale 
Xiaoning Yuan 
 
The menisci are fibrocartilaginous tissues of the knee that specialize in load-bearing and 
stabilization of the joint. Though once believed to be “the functionless remains of leg muscles,” 
and therefore routinely removed after injury, it is now understood that loss of meniscus 
integrity leads directly to degenerative changes in the knee, inspiring new pursuits to 
overcome the intrinsic limitations to meniscus repair. However, many components of the 
meniscus environment and their roles in regulating the cellular response of injured tissue 
remain unclear. This thesis presents novel strategies to enhance integrative repair of the 
meniscus, via control of the cell environment from the micro- to macro-scale. The unifying 
hypothesis of this dissertation was that the application of chemical, physical, and 
environmental factors can significantly influence the meniscus cell environment and contribute 
to healing. Specifically, we studied the direct role of vasculature on the meniscus, and 
identified angiogenic factors that regulate cell migration and tissue repair between the inner 
and outer regions. We analyzed the effects of pulsatile direct current electrical stimulation on 
meniscus cell migration and repair, and describe the mechanisms of electrotransduction in the 
meniscus. Finally, we developed a decellularized meniscus extracellular matrix hydrogel to 
deliver and dictate the behavior of stem cells for meniscal repair. By rigorous study of each 
element at the micro-scale and integration at the macro-scale, novel therapies for meniscus 
repair will emerge towards clinical applications. 
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Chapter 1. Introduction 
The meniscus contributes significantly to the biomechanical function of the knee joint in daily 
life and activity1–3, and if this essential function is lost, the knee becomes susceptible to the 
degenerative joint changes associated with osteoarthritis4–7. Clinical management of meniscal 
injury is therefore essential to prevent these degenerative changes1,8. However, the extent of 
innate repair is determined largely by the location of the injury: while meniscus tears in the 
outer, vascular tissue region undergo repair, those in the inner, avascular region do not9,10. This 
regional variation within the meniscus has led to efforts towards novel strategies that 
overcome the limited healing potential of injuries to the inner meniscus11–14. 
 
This dissertation investigated the roles of relevant chemical, physical, and environmental 
factors influencing meniscus repair, in order to promote healing of both the inner and outer 
regions of the meniscus. The focus was on the design of micro-scale systems for screening 
specific components governing meniscus cell migration, towards the development of 
therapeutic regimes for macro-scale meniscus repair. The unifying hypothesis was that control 
of the meniscus cell environment via application of paracrine, electrical, and matrix-derived 





Chapter 2 begins by depicting the significance of our work on the meniscus in the clinical 
context, and providing background on the relevance of vasculature, electrical signals, and the 
extracellular matrix to meniscal repair. It continues by outlining how each of these factors, 
chemical (vasculature), physical (electrical signals), and environmental (extracellular matrix) 
constitute parameters that can be optimized and used to control cell behavior and thereby 
improve the outcome of meniscal repair. 
 
Chapter 3 describes our study into the direct role of vasculature on meniscus cell migration 
and tissue repair. Regional differences in meniscus repair are theorized to be due to the 
presence of vascularization exclusively in the outer region9. Consequently, clinical techniques 
have relied on improving vascular access to the inner region9,10,15. However, the direct effects of 
endothelial cells (ECs) on meniscus repair remain unclear, and specifically, their role in cell 
migration. The specific hypothesis was that ECs regulate the migration of meniscus cells from 
both the inner and outer regions. The approach was to first establish a three-dimensional 
micropatterned hydrogel system to study the interactions between meniscus and endothelial 
cells in vitro, and identify the paracrine signals involved in EC-mediated cell migration. The 
significance was to then apply understanding of this migration behavior at the micro-scale 
towards enhancing repair of a full-thickness defect model in meniscal explants at the macro-
scale. Our studies have identified a novel role for the angiogenic factor, endothelin-1, in 




Chapter 4 analyzed the effects of pulsatile direct current electric fields on meniscus cell 
migration and tissue repair. Electrical stimulation has widespread applications in the 
rehabilitation of musculoskeletal injuries16, but its utility in meniscus repair remains largely 
unexplored. The specific hypothesis was that pulsatile direct current electric fields can control 
the migration of meniscus cells. The approach was to characterize the 3-D migration behavior 
of inner and outer meniscus cells in EFs and optimize electrical stimulation parameters, with 
the combination of a micropatterned hydrogel migration assay and custom bioreactor system. 
The significance was that the screening and design of optimal electrical stimulation regimes for 
cell migration on the micro-scale significantly improved meniscus healing on the macro-scale, 
by promoting integrative repair of full-thickness defects in meniscus explants. We also 
provided the first evidence implicating the adenosine A2b receptor in electrotransduction of 
signals to the meniscus. 
 
Chapter 5 narrates our development of a hydrogel scaffold derived from the meniscus 
extracellular matrix for tissue repair. Natural scaffolds made from the ECM of decellularized 
tissues preserve specific molecules that guide the behavior of new cells and facilitate tissue 
development, without the immunogenic components17. In particular, the meniscus is 
composed of a unique extracellular matrix (ECM), containing collagens and proteoglycans18 
that contribute to its biomechanical properties. The specific hypothesis was that decellularized 
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meniscus ECM retains native molecules, which can provide cues towards the formation of new 
repair tissue. The approach was to create a protocol for decellularization of meniscus tissue and 
preparation in hydrogel form, and induce fibrochondrogenesis of mesenchymal stem cells 
(MSCs) in decellularized meniscus ECM (mECM) hydrogel. The significance was that mECM 
hydrogel delivered MSCs into a meniscal explant model of a full-thickness defect and directed 
the formation of new fibrocartilage tissue by MSCs for integrative repair. 
 
Finally, chapter 6 recaps our progress in decoupling the contributions of vascular, electrical, 
and extracellular matrix signals for meniscal repair, and elucidating the novel mechanisms 
underlying the effects of each factor in the meniscus. We discuss the value of our findings in 
the context of the field, their current limitations, and their implications for future advances in 
engineering meniscal repair and regeneration.  
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Chapter 2. Background 
2.1. Clinical significance 
Osteoarthritis is among the top ten disabling conditions in high-income countries19. Partial 
meniscectomy, or excision of damaged meniscus tissue, is the most common procedure 
performed by orthopaedic surgeons20. However, the relationship between osteoarthritis and 
meniscal damage was not recognized until up to the end of the twentieth century. In fact, the 
consequences of total meniscectomy, or complete removal of the meniscus, the preferred 
method of treatment at the time, came only with longitudinal follow-up studies of patients at 
ten to twenty years after surgery21,22. What surgeons discovered was startling: radiographic 
changes consistent with OA, in concert with decreased knee function and other symptoms 
characteristic of OA. In fact, pathologic changes of the meniscus have since been identified in 
up to 91% of patients with symptomatic knee OA23. 
 
 
Figure 2.1. Partial meniscectomy of meniscal tears. 
The menisci with (a) radial and bucket-handle tears and after (b) partial meniscectomy of the damaged tissue, 




Since then, the consensus among orthopaedic surgeons has been to repair tears of the meniscus 
when possible, and to preserve native tissue when repair is not possible24 (Figure 2.1). Meniscal 
repair is attempted by various suturing techniques (Figure 2.2), and can be performed under 
open surgery or by arthroscopy25. Regardless of the technique, repairs require weeks of 
immobilization and months of limited, strenuous activity following the procedure. 
 
 
Figure 2.2. Suturing techniques for meniscus repair. 
The three primary techniques for meniscal repair involve suturing techniques that enter from the tissue 
periphery inwards (outside-in), from the inner surface outwards (inside-out), or enter and exit through the inner 
region only (all-inside; adapted from ref. 26). 
 
However, repair is successful in only a fraction of cases, most favorably in younger patients 
with traumatic meniscal tears of the outer, vascular zone (Figure 2.3). For the majority of 
patients, partial meniscectomy is the more common treatment for meniscal tears, particularly 
in the inner, avascular zone of the tissue. It is injury to this region of meniscus that is of 
particular interest, as partial meniscectomy has not been definitively shown to improve the 
clinical outcome of older patients who present with degenerative, age-related meniscal tears, 
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by preventing or delaying the onset of OA, compared to non-surgical treatment options27,28. 
However, in contrast to meniscal repairs, both partial and total meniscectomies do not require 




Figure 2.3. Regional variation in vascularity within the meniscus. 
The treatment of meniscal tears (top right) is dependent on its location within the tissue. Whereas tears in the 
outer, vascular region can be repaired, tears in inner, avascular zone cannot heal and require excision. The 
relative vascularity of the inner versus outer regions underlies their designation as the white versus red zone 
(bottom; adapted from realsurgery-meniscustear.com). 
 
It is notable, despite the limitations to their application, that both open and arthroscopic repairs 
have been successful in the long-term. This represents an opportunity for advancing research, 
in order to overcome the limitations to repair achieved in tears of the avascular zone. 
Moreover, the difference in recovery time after repair versus after meniscectomy invites the 
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prospect of developing treatments that decrease healing time. Finally, the temporal 
relationship between meniscal damage and osteoarthritis development presents clinicians and 
scientists alike with a fascinating prospect for treatment: by reverting the meniscus to its native 
structure and function, we may delay or even prevent the onset of osteoarthritis. 
 
2.2. The meniscus 
The menisci are a pair of semilunar, fibrocartilaginous tissues in the knee, medial and lateral, 
which are wedge-shaped in order to accommodate and maintain the intra-articular space 
between the femur and tibia (Figure 2.4). The meniscus and its unique composition of cells, 
vasculature, and extracellular matrix comprise a structure that is essential in bearing load and 
maintaining congruency of the knee. The menisci also impart stabilization to the knee joint, in 
concert with the anterior and posterior cruciate ligaments, and medial and lateral collateral 
ligaments. The medial and lateral menisci are themselves connected by the transverse 
ligament, and both ends of the menisci, known as the anterior and posterior horns, are directly 
attached to the tibial plateau. The outer zone of the meniscus is strongly invested in synovial 
membrane, which also provides vasculature to this region, whereas the inner zone is avascular. 





Figure 2.4. Anatomy of the knee joint. 
The medial and lateral menisci reside between the cartilaginous femoral and tibial surfaces of the knee joint. 
Along with the knee ligaments (ACL, PCL, MCL, LCL), the menisci stabilize the joint, as well as  transmitting and 
distributing loads (adapted from ref. 29). 
 
During physiologic loading, the menisci experience tension, compression, and shear, enabled 
by their complex collagenous matrix (Figure 2.5). It has been estimated that the menisci 
support 45-75% of the load experienced by the knee joints, which ranges from 2.7-4.9 times 
body weight30,31. Intact medial and lateral menisci cover two-thirds of the tibial plateau and 
10 
 
limit the contact surface between the femur and tibia to 10%32. If this tissue is excised, even 
physiologic forces experienced by the joint can increase the stress on the hyaline cartilage 
surfaces by two- to three-fold, thereby contributing to OA etiology33 . 
 
 
Figure 2.5. Collagen fiber orientation in the meniscus enables mechanical loading. 
(a) The organization of collagen fibers within the meniscus allows for mechanical loading in tension, 
compression, and shear. Superficially, collagen fibers are oriented randomly at the surface, whereas the 
deeper zones consist of circumferential fibers interposed with radial tie fibers (adapted from ref. 34). (b) When 
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the menisci experience loads physiologically (FA), an associated reaction force is generated at the tibial plateau 
(Rz). Radial forces outward (fr) are balanced by forces generated in the anterior and posterior horns (fa, fp), 
which together lead to tensile hoop stresses (tc; adapted from ref. 35).  
 
The biochemical composition of the meniscus also varies by region. Specifically, the outer 
region is more fibrous in nature and is composed of ~80% type I collagen by dry weight36,37. In 
contrast, the inner region is more cartilaginous, composed of ~40% type I collagen and ~30% 
type II collagen by dry weight38. The remainder of the tissue is composed of ~15% 
glycosaminoglycans (GAGs), which attach to a core protein to form proteoglycans (PGs), ~2% 
DNA, and other proteins39. The negatively charged GAGs hydrate the tissue, contributing to its 
compressive properties, and also allow for electrical activity40, with PG synthesis more closely 
associated with cells of the inner region41. 
 
Meniscal cells are not homogeneous throughout the tissue, but have both fibroblast- and 
chondrocyte-like characteristics, and are therefore designated as meniscal fibrochondrocytes 
(MFCs). Cells in the more cartilaginous inner zone are chondrocyte-like, while those of the 





Figure 2.6. Regional variation in phenotype of meniscal fibrochondrocytes. 
Meniscal cells are known as fibrochondrocytes and vary in phenotype within the meniscus. Meniscal 
fibrochondrocytes in the outer region, which also contains vessels, are more fibroblast-like, while those in the 
inner region, are more chondrocyte-like. Scale bar: 100 µm (adapted from refs. 29,42). 
 
Isolation of cells can be performed by enzymatic digestion43 or explant outgrowth42. Recently, a 
population of bovine MFCs isolated by explant outgrowth was found to possess the ability to 
differentiate along multiple lineages, demonstrating cell plasticity that may indicate and 
contribute to endogenous repair42. Notably, these cells were found in both the outer, vascular 
zone, which is known to exhibit healing potential, as well as in the inner, avascular zone, which 
does not. From this study, we know of the existence of endogenous cells that can be induced to 
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repair tears in either region of the meniscus. However, under the pathological conditions 
typically associated with tears of the inner zone, repair does not occur.  
 
In articular cartilage, the loss of aggrecan, the predominant proteoglycan in the tissue, is an 
early event in arthritis, leading to collagen degradation, and eventual loss of mechanical 
properties44. Likewise, after meniscus injury, the delicate balance maintained by the presence of 
PGs is lost, and a downward cascade ensues45. The synovial environment after injury has 
elevated levels of IL-1 and TNF-α46–48, which act in concert to increase the production of nitric 
oxide (NO), prostaglandin E2 (PGE2), matrix metalloproteinases (MMPs), increase the release of 
PGs, and decrease the synthesis of collagen in both meniscus cells and explants49–54.  
 
If we take advantage of the catabolic environment present in the meniscus after injury, we have 
an opportunity to develop and apply therapies that can revert the tissue to its previous state of 
homeostasis. Degradation of the dense meniscal extracellular matrix permits the migration of 
endogenous repair cells to the site of the injury, given the proper stimuli. The release of matrix 
components can in turn instruct the synthetic activities of migrating endogenous cells, or 
exogenous cells delivered directly to the tear.  To this end, achieving a new balance between 
catabolic tissue degradation and anabolic tissue synthesis motivates our search for strategies 




2.3. Meniscus repair 
2.3.1. Role of vascularization in meniscus repair 
As noted, the success of meniscus repair is largely dependent on the location of the tear within 
the tissue: specifically, if the tear occurs in part within the outer, vascular zone, also known as 
the red zone, it can heal, but if it is contained exclusively within the inner avascular, or white 
zone, healing does not occur. Therefore, general wisdom in orthopaedics has been that 
vascularity is necessary for healing, and a variety of attempts have been made to increase the 
vascular response of the otherwise avascular inner region, such as meniscal rasping55,56, 
trephination57, implantation of a fibrin clot58,59, and creation of vascular channels9,60. However, 
vascularity alone does not necessarily explain the differences between healing in the inner and 
outer zones. An in vitro study of tissue explants from the inner and outer regions in an organ 
culture model removed the overt influence of vascularity, but nevertheless demonstrated 
differences in repair between the two regions, suggesting that they inherently vary in healing 
ability61. In contrast, a related study in a full-thickness defect model of meniscal explants 
reported no differences in repair in vitro62. In a sense, these conflicting results underscore the 
general complexity of meniscal repair, but they also suggest that there exists potential for the 
inner and outer regions to heal similarly, given the proper set of cues and conditions. 
 
This complexity within the meniscus relates back to the changes in vascularity that occur with 
age. The fetal meniscus is fully vascularized, but a decrease in vascularity initiates soon after 
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birth, and by early adolescence, the meniscus is differentially vascularized like the adult 
tissue63. The medial, lateral, and middle geniculate arteries, arising from the popliteal artery, 
supply blood to the outer zone only, up to 30% of the medial meniscus and 25% of the lateral 
meniscus64–67. These changes may be precipitated by increases in weight and joint motion with 
age68. Nevertheless, as we age, the nutritional supply to the outer meniscus occurs by perfusion 




Figure 2.7. Vascularity of the meniscus from fetal to adult. 
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(a) The fetal meniscus is fully vascularized, but the regional variation in vascularity initiates soon after birth and 
is complete by early adolescence (adapted from ref. 26). Vascular perfusion within the meniscus with a 
modified Spalteholz technique in the (b) fetal and (c) adult meniscus  (adapted from ref. 66). 
 
After maturation, maintenance of the vascular boundary appears to be achieved by the 
endogenous production and presence of anti-angiogenic factors, primarily in the inner 
meniscus. Endostatin, a fragment of collagen XVIII that is generated during matrix remodeling, 
inhibits VEGF activity, and has been detected at higher concentrations in the avascular zone of 
adult human menisci70. Chondromodulin-I, an inhibitor of endothelial cell proliferation and 
activity, was also preferentially detected in the inner zone of adult human menisci71. 
 
However, simply inducing vascularization in meniscal tissue does not promote its healing or 
the development of physiologic mechanical properties. Subcutaneous implantation of MFC-
seeded PGA scaffolds induced extensive vascularization throughout the constructs72. However, 
no corresponding increase in mechanical properties was observed. This does not come as a 
surprise, as these properties occur in native meniscus, as well as in articular cartilage, as the 
result of a highly organized matrix, with little to no interruption of this organization by the 
presence of vasculature. 
 
In fact, neovascularization of meniscus has been observed in human menisci with OA post-
mortem73. Indeed, VEGF and associated angiogenesis in diseased articular cartilage and 
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annulus fibrosis have been previously described74. Again, the presence of vascularization in 
otherwise avascular regions of tissue disrupt normal biomechanics, which lead to further tissue 
damage and pathologic remodeling, rather than protection of the native tissue. This brings us 
back to the primary focus of this thesis: how to re-establish homeostasis in the meniscus after 
injury. Rather than irreversibly traversing a pathway of matrix destruction, we hope to achieve 
a new balance between degradation and synthesis.  
 
2.3.2. Application of electrical stimulation for meniscus repair 
Electric fields are known to provide spatial cues that guide embryonic development and tissue 
regeneration75–77. However, the precise role of electrical signals in regulating the biosynthetic 
activity and homeostasis of non-conductive tissues, and how these actions could be applied 
clinically, remain elusive. In the context of connective tissue repair, specifically, the clinical use 
of electrical stimulation has been largely limited to the healing of skeletal injuries, although 
both preclinical and clinical studies have also demonstrated its efficacy in the repair of articular 
tissues16. 
 
The existence of endogenous electrical potentials during physiological loading of articular 
cartilage has been well-studied in both theoretical78–80 and experimental81–85 models, such that 
electrical signals have been implicated as the intermediary that transduces mechanical signals 
to cells within tissues81,86,87. A variety of electrical stimulation modalities have been previously 
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shown via in vitro 2-D and 3-D models of cartilage and in vivo repair models88–90 to significantly 
increase cell proliferation91,92 and proteoglycan synthesis93,94, upregulate the expression of 
extracellular matrix genes95, and reduce the production of inflammatory cytokines and 
enzymes such as IL-1 and MMPs96. Deformation of the meniscus and subsequent electrical 




Figure 2.8. Electrical activity of calf meniscus during compressive loading. 
Traces for load and electrical activity in an explant of calf meniscus (1 cm × 1 cm × 2 cm), in compression 
perpendicular to the dominant fiber axis. Electrical activity revealed an initial voltage spike (1-4 mV), followed 
by a sustained potential, attributed to piezoelectric effects and the contribution of streaming potentials, 
respectively (adapted from ref. 84) . 
 
Likewise, experimentally induced degradation of charged proteoglycans in cartilage has also 
been shown to cause significant changes in endogenous electrical signals97,98. In an effort to 
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restore the naturally occurring signals produced during physiological loading of the knee, 
BioniCare® is a non-invasive FDA-approved device delivering pulsed electrical stimulation for 
treatment of osteoarthritis of the knee. The system has been shown clinically in candidates for 
total knee replacement to delay the procedure for four years or more99. Sustained use in 
patients who had exhausted other non-surgical options led to further improvement of OA 
symptoms100. 
 
However, many questions remain as to how electrical signals influence cells and propagate 
their effects, particularly in the meniscus. Previously, the existence of a stimulus-receptor 
system on the chondrocyte membrane was proposed, which transduced mechanical or 
electrical signals, acting on adenylyl cyclase and cyclic nucleotides such as cAMP101, a second 
messenger that relays intracellular signals. Supporting this theory, the application of either 
static mechanical forces or constant electric currents on periosteal osteoblasts and periodontal 
ligament cells was found to activate cAMP102. Elevated cAMP also results from the activation of 
adenosine receptors, specifically the high-affinity A2a and low-affinity A2b receptors. In the 
presence of adenosine, the G protein-coupled receptors A2aR and A2bR stimulate adenylyl 
cyclase via Gs, which in turn activates cAMP103. In cartilage, TNF-α production as a result of 
inflammatory conditions leads to adenosine release and subsequent activation of the A2aR on 
chondrocytes104. This leads to an increase in intracellular cAMP, and then activation of anti-
inflammatory pathways via protein kinase A and EPAC, which in turn lead to the suppression 
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of NO and PGE2104 and downstream feedback inhibition of TNF-α and IL-1β105. Conversely, the 
depletion of adenosine led to increased GAG release, and production of MMPs and NO in 
equine chondrocytes and cartilage explants106,107. Adenosine has also been implicated in 
mediating the anti-inflammatory effects of methotrexate in the treatment of rheumatoid 
arthritis (RA)108–110. Rodent models treated with a combination of methotrexate and adenosine 
receptor antagonists lost the anti-inflammatory benefits of the drug111, and a similar loss in 
efficacy has been seen clinically112. The ubiquitous adenosine receptors have also been 
implicated in the electrotransduction of pulsed electromagnetic fields (PEMFs) in cartilage. 
Activation of A2aR and A3R in bovine chondrocytes113 and human OA synovial fibroblasts114, 
and A1R and A2aR in bovine synovial fibroblasts115, occurred with application of PEMFs. 
Induction of inflammatory responses by treatment with TNF-α115, lipopolysaccharide (LPS)115, 
or IL-1β114 led to PGE2 release by cells, but this was inhibited upon exposure to PEMFs, 
suggesting roles for adenosine receptors in eliciting anti-inflammatory responses in cartilage. 
Taken altogether, it can be hypothesized that electrical stimulation may also prove a useful tool 
to enhance repair of the meniscus, and control the inflammatory events underlying tissue 
degradation. 
 
2.3.3. Extracellular matrix-derived biomaterials for meniscus repair 
The extracellular matrix (ECM) of the meniscus is yet another component that varies within the 
tissue. The complex properties of the meniscus arise from a biochemical composition chiefly of 
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water (65-70%), and a solid matrix of collagens, noncollagenous proteins, including 
proteoglycans, and others such as adhesion proteins69 (Figure 2.9). 
 
Analysis of the collagens present in the bovine meniscus by region yielded total collagen 
constituting 70% of the dry weight of the inner region37. Of this, 34% was pepsin-soluble, and 
moreover, 60% was type II collagen, with type I dominating the remainder. The contribution of 
collagen to the dry weight of the outer meniscus was higher at 80%, but only 20% of the region 
overall was pepsin-soluble. Of this, 95% was type I, and types III and V comprised the 
remainder. Type VI collagen is also a component of the ECM, and plays a significant role in the 
pericellular matrix immediately surrounding the MFCs116,117. Type VI collagen is also among 
the small percentage of adhesion proteins within the meniscus, which aid in interactions 
between cells and other ECM components, and include fibronectin and thrombospondin as 
well18,118. 
 
The major noncollagenous proteins are the proteoglycans, which are characterized as a protein 
core with attached GAG chains (chondroitin 4- and 6-sulfate, keratan sulfate) that non-
covalently bind hyaluronic acid, stabilized by link protein. These proteoglycans in the 
meniscus ECM include the major large proteoglycan, aggrecan119, the small leucine-rich 






Figure 2.9. The ECM composition of the meniscus in cross-section. 
(a) The organization of collagen fibers within the meniscus, comprising randomly oriented fibers in the 
superficial zone, and in the deeper zones, circumferentially oriented fibers and radial tie fibers (adapted from 
ref. 36). (b) Histological staining of bovine menisci for collagens (Picrosirius red; top) and sulfated GAGs (Alcian 
blue; bottom) demonstrates changes in ECM composition that occur with age. Scale bar: 100 µm (adapted 
from ref. 121). 
 
ECM composition not only varies by region in the tissue, but also changes with age and 
disease. During development, the menisci form via mesenchymal condensation by the eighth 
week, but at this early time point, fibroblasts rather than chondrocytes comprise the cells 
within the tissue. As the fetus ages, the meniscus ECM gains collagens, which begin to orient 
circumferentially as a result of joint motion in utero. The collagen content of human menisci 
increases with age, and is then maintained between the third and eighth decade, at which point 
23 
 
it declines2,18. Conversely, noncollagenous proteins including proteoglycans decline from birth 
to a steady level between the ages of 50 to 70 years, then increase again. To this end, overall 
increases in GAG content have been shown to correlate with meniscal damage and 
degeneration122,123. In animal models of OA, both naturally occurring and experimentally 
induced, this late increase in GAGs follows an earlier decrease, which was also seen in human 
menisci124. These temporal changes suggest an environment in which tissue integrity has been 
compromised, indicated by the initial decrease in GAGs, and the subsequent attempt to 
compensate for this by increasing GAG production. Age is a particularly relevant factor in the 
menisci, in the context of tissue damage and healing potential. Previously, an in vitro model of 
meniscal repair demonstrated superior healing of fetal and juvenile bovine explants, whereas 
adult tissue in the same system did not exhibit healing121. This leads naturally to the question, if 
replicating the ECM composition of young menisci may be beneficial in stimulating cell 




Chapter 3. Endothelial cells enhance migration of meniscus cells 
3.1. Abstract 
Our objective was to study the interactions between vascular endothelial cells and meniscal 
fibrochondrocytes (MFCs) from the inner avascular and outer vascular regions of the 
meniscus, and identify angiogenic factors that enhance cell migration and integrative repair. 
Bovine MFCs (bMFCs) from the inner and outer regions of meniscus were cultured for seven 
days with and without human umbilical vein endothelial cells (HUVECs) in a micropatterned 
three-dimensional hydrogel system for cell migration. Angiogenic factors secreted by HUVECs 
were probed for their role in paracrine mechanisms governing bMFC migration, and applied 
to a full-thickness defect model of meniscal repair in explants from the inner and outer regions 
over four weeks. We found that endothelial cells enhanced migration of inner and outer cells in 
the micropatterned system via endothelin-1 (ET-1) signaling. Supplementation of ET-1 
significantly enhanced integration strength of full-thickness defects in inner and outer explants, 
and cell migration at the macro-scale, compared to controls without ET-1 treatment. We report 
for the first time that bMFCs from both the avascular and vascular regions respond to the 
presence of endothelial cells with increased migration. Paracrine signaling by endothelial cells 
regulates bMFCs differentially by region, but we identify ET-1 as an angiogenic factor that 
stimulates migration of inner and outer cells at the micro-scale, and integrative repair of inner 
and outer explants at the macro-scale. These findings reveal the regional interactions between 
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vasculature and MFCs, and suggest ET-1 as a potential new treatment modality for avascular 
meniscal injuries, in order to prevent the development of osteoarthritis. 
 
3.2. Introduction 
Osteoarthritis and degenerative changes in the knee can result from injuries to the menisci, 
fibrocartilaginous tissues that specialize in load-bearing and stabilization of the joint8,125. 
Historically, total meniscectomy was performed after meniscal insult126, but it is now 
appreciated that the amount of resected tissue correlates with the severity of subsequent OA127. 
Notably, repair of meniscal injuries occurs only in the outer region, while tears in the inner 
region cannot heal and require removal by partial meniscectomy. The outer region comprises 
approximately one-third of the meniscus and is vascularized, whereas the inner region lacks 
vascularity64,128. This regional variation in vascularization is believed to underlie the differences 
in healing potential within the meniscus, and has inspired pursuits to improve the vascular 
response of the inner meniscus and overcome its intrinsic limitations in repair129,130. However, 
the interactions between vascular endothelial cells and meniscus cells are not well understood, 
particularly the paracrine effects of endothelial cells (ECs) on meniscus cell migration and 
repair. 
 
Vascular development by ECs requires a specialized cast of players, specifically VEGF, 
endothelin-1 (ET-1), and PDGF131. VEGF-A is necessary for regulation of ECs and angiogenesis, 
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and interacts with VEGF receptors 1 and 2 on ECs and other cell types132. ET-1 is closely 
associated with angiogenesis, and cooperates with VEGF-A for vascular formation in vivo133. 
When VEGF-A couples with PDGF-BB, vessel stabilization and maturation result from the 
recruitment of supporting cells by PDGF receptors α and β134,135. In the context of the meniscus, 
VEGF-A and its receptors were detected in normal136 and healing137 tissue in vivo, and PDGF 
promoted 2-D migration of meniscus cells in vitro138. In contrast, a role for ET-1 in meniscus has 
yet to be investigated, although it has been previously studied in cartilage139–141. 
 
Given the regional interplay between vasculature and meniscus in healing, and the 
overlapping activity of factors relevant in both, we examined the paracrine effects of 
endothelial cells on migration of meniscus cells using an in vitro system for cell patterning in 
three-dimensional hydrogel142. We focus on the use of relevant micro-scale systems to identify 
the specific mechanisms governing EC-mediated meniscus cell migration, and apply these to a 
macro-scale model of meniscal repair. We hypothesize that control of the meniscus cell 
environment via application of paracrine signals can compensate for native differences in 




3.3. Materials and Methods 
3.3.1. Cell and explant culture 
The menisci of juvenile bovine calves were dissected within 36 h of slaughter (Green Village 
Packing Company), and sectioned into inner (2/3) and outer (1/3) regions42. For cell isolation, 
tissue was minced into 1-2 mm3 pieces, and plated on tissue culture plates in basal medium 
(BM; high glucose DMEM, 1× antibiotic-antimycotic, 10% FBS, 50 μg/mL ascorbate 2-
phosphate). After 2-3 weeks, cell outgrowth from tissue pieces was collected and expanded to 
passage 2. For meniscal explants, cylindrical cores were harvested from the inner and outer 
regions using 4 mm Ø biopsy punches, and cut to 1.5 mm height using a custom microtome 
device. To model a full-thickness defect, a 1.5 mm Ø central core was punched and 
immediately replaced into the explant ring. Explants were maintained in BM for 3 days before 
the start of an experiment, and then cultured in endothelial growth medium (EGM-2; Lonza) 
alone or EGM-2 supplemented with 10 ng/mL endothelin-1 (human, porcine; Tocris) over 28 
days, with biweekly time points for mechanical integration testing, DNA quantitation, and 
histological analysis. 
 
Human umbilical vein endothelial cells (HUVECs) were isolated from fresh umbilical cords, 
according to an approved IRB protocol at Columbia University, and fully de-identified at the 
time of receipt143. Umbilical vein lumens were rinsed with PBS, infused with a 2.5% trypsin 
solution, and clamped at both ends for 15 min at 37 °C. The resulting cell digest was collected 
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by rinsing with PBS and centrifuging at 300 × g for 5 min. The cell pellet was resuspended in 
EGM-2, and expanded to passage 5. Media was collected during monolayer expansion from 
passages 4 to 5 (HUVEC-conditioned medium) for use in conditioned medium studies. 
 
In initial experiments, bovine meniscal fibrochondrocytes (bMFCs) and HUVECs were pre-
labeled with CellTracker CM-DiI and SP-DiOC18(3) (Invitrogen), respectively, according to 
manufacturer’s protocol, but subsequent studies omitted this labeling step. 
 
3.3.2. Cell migration assays 
The micropatterned three-dimensional hydrogel system was previously designed to study the 
migration of human mesenchymal stem cells in co-culture with HUVECs142. Briefly, the cured 
poly(dimethylsiloxane) (9:1 elastomer:curing agent; Sylgard 184 silicone elastomer kit; Dow 
Corning)  micropattern consisted of parallel channels (1 cm length, 1000 μm width, 200 μm 
height, channel-to-channel distance: 2000 μm; Figure 3.1a) with 1 mm Ø inlets for injecting the 
cell-hydrogel suspension142. 
 
For co-culture studies, inner or outer cells were resuspended in 2.0% fibrinogen (bovine 
fibrinogen; MP Biomedicals) at 3.5×106 cells/mL, and HUVECs at 3.5×106 or 7×106 cells/mL, then 
mixed with thrombin (10 U/mL; from bovine plasma; Sigma-Aldrich) at a 9:1 ratio. The 
resulting 1.8% fibrin hydrogel was printed into parallel channels on non-tissue culture-treated 
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plastic, allowed to polymerize for 15 min, and covered by another layer of 1.8% fibrin to permit 
cell migration. 
 
For conditioned medium experiments, single channels of inner or outer cells were cultured in a 
1:1 mixture of HUVEC-conditioned medium and EGM-2. For angiogenic factor studies, single 
channels of bMFCs were supplemented with endothelin-1, PDGF-BB, or VEGF165, an isoform 
of VEGF (recombinant human; Peprotech), at 10 or 100 ng/mL. For neutralizing antibody 
studies, ET-1 antiserum (rabbit anti-human; 1:2040 dilution; Peptides International), anti-
PDGF-BB antibody (rabbit anti-human; 1.2 µg/mL; Peprotech), or anti-VEGF-A antibody 
(rabbit anti-human; 0.5 µg/mL; Peprotech) was added to co-cultures. For receptor antagonist 
studies, endothelin receptor type A (ETAR) antagonist (BMS 182874 hydrochloride; 48 nM; 
Tocris), PDGFRα/β inhibitor (PDGFR tyrosine kinase inhibitor III; 0.08 μM; Millipore), and 
VEGFR1/2 inhibitor (ZM 306416 hydrochloride; 2 μM; Tocris) was added to co-cultures. In all 
studies, single channels of bMFCs served as controls. 
 
Cultures were maintained in EGM-2, unless otherwise specified, over seven days after 
encapsulation, and migration was monitored at days 0 and 7, using an Olympus IX81 
microscope. Bright field images were processed using a custom MATLAB code144 to analyze 
cell migration, by applying the Sobel edge detection algorithm and eliminating small regions of 
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single, isolated bMFCs. Images of each sample were subdivided into regions of ~1580 µm of 
the channel length, yielding average channel-to-channel distances per region. 
 
3.3.3. Gene and protein expression of cells and media 
For gene expression, total RNA of encapsulated bMFCs after seven days of culture was 
extracted by TRIzol reagent (Invitrogen) and reverse transcribed to cDNA (High Capacity 
cDNA Reverse Transcription Kit; Applied Biosystems). Prior to encapsulation, inner and outer 
cells were processed to calculate fold change (2-ΔΔCT). cDNA amplification was performed on an 
Applied Biosystems StepOnePlus Real-Time PCR System, using Fast SYBR Green Master Mix 
(Invitrogen), and custom bovine primers for EDNRA, PDGFRA, PDGFRB, FLT1, KDR, and 
GAPDH. 
 
For protein analysis of culture media, human angiogenesis arrays (R&D Systems) were 
performed on EGM-2 and HUVEC-conditioned medium, according to manufacturer’s 
protocol. Arrays were exposed using a Kodak Image Station 4000MM Pro, and analysis of spot 
pixel density performed in Fiji. For protein quantification, media were collected from culture of 
bMFCs with and without HUVECs over seven days in EGM-2, and precipitated to concentrate 
proteins. Briefly, aliquots were mixed at a 4:1 ratio with trichloroacetic acid and incubated on 
ice for 30 min before centrifugation at 4°C for 15 min at 12,000 × g. The protein pellet was 
washed with 300 μL cold acetone and centrifuged at 4°C for 5 min at 12,000 × g, before drying 
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and resuspending in 4% BSA in DPBS. ET-1 (Quantikine ELISA kit; R&D Systems), PDGF-BB, 
and VEGF-A (human ELISA kits; Sigma-Aldrich) were measured in the precipitated samples, 
according to manufacturers’ protocols. 
 
3.3.4. Mechanical integration testing and DNA quantitation of explants 
Integration of full-thickness defects in explants was tested, according to a previously 
established method145. Briefly, a custom device, consisting of a 1.33 mm Ø indenter in series 
with a 50 g load cell, was displaced downwards through a 2 mm Ø hole in the cup containing 
the sample. Prior to testing, the height of each sample was measured using a digital caliper. 
The indenter was displaced at a ramp rate of 0.3% of the sample height per second, until the 
central core was pushed through the ring. Integration strength was calculated by the ratio of 
the peak force measured to the surface area of contact between the core and ring. After testing, 
samples were collected for DNA quantitation. Briefly, explants were lyophilized for 24 h and 
digested at 60°C for 16 h in a solution containing 125 µg/mL papain (Sigma-Aldrich), 50 mmol 
phosphate buffer (pH 6.5), and 2 mmol N-acetyl-L-cysteine (Sigma-Aldrich). Total DNA 





3.3.5. Histological and immunofluorescence staining of cells and explants 
For immunofluorescence staining, the following primary antibodies were used for bMFCs: 
rabbit anti-endothelin receptor A (1:200; Millipore), rabbit anti-PDGFRα (1:50; Santa Cruz 
Biotechnology), rabbit anti-PDGFRβ (5 μg/mL; Abcam), rabbit anti-Ki-67 (10 μg/mL; Abcam). 
For HUVECs, sheep anti-von Willebrand Factor antibody (1:100) was purchased from Abcam. 
For all samples, DAPI (1:200; Invitrogen) staining was performed to visualize cell nuclei. The 
secondary antibodies were Alexa Fluor 488 donkey anti-sheep IgG and 555 goat anti-rabbit IgG 
(1:200; Invitrogen). 
 
For cell migration studies, samples were fixed for 10 min each in a graded series of 
formaldehyde (1-4%). Briefly, samples were blocked and permeabilized with agitation in PBS 
containing 5% BSA and 0.1% Triton X-100 for 1 h at 25°C, and incubated overnight at 4°C with 
primary antibodies in PBS with 5% BSA. After 3 washes of 30 min each at 25°C in PBS with 
agitation, samples were incubated at 4°C overnight with secondary antibodies and DAPI, 
followed by 3 additional washes. 
 
For integration studies, samples were fixed in 4% formaldehyde overnight at 4°C, 
encapsulated in 2% low-melting-temperature agarose, dehydrated in a graded series of 
ethanol, embedded in paraffin, and sectioned to 8 μm thickness. Sections were stained with 
hematoxylin and eosin to visualize nuclei and cytoplasmic elements. For immunofluorescence 
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staining, antigen retrieval was performed with 10 mM citrate buffer (pH 6.0), followed by 
blocking, primary and secondary antibody incubations, as previously described. All stained 
samples were imaged with an Olympus FSX100 microscope. 
 
3.3.6. Statistical analysis 
For cell migration studies, 1-way ANOVA with Tukey post-tests were performed with Prism 
(α = 0.05). For integration studies, 2-way ANOVA with Bonferroni post-tests were also 
performed with Prism. All data are presented as mean ± SEM. 
 
3.4. Results 
3.4.1. Endothelial cells enhance migration of meniscus cells 
Meniscus cells demonstrated migration in the micropatterned hydrogel system by day 3 
(Figure 3.1b), establishing the validity of the assay for investigating their 3-D migration 
behavior (Figure 3.1a). Migration of inner and outer cells corresponded with changes in 
morphology from more rounded at day 0 to more spread-out at day 3. The bMFCs, isolated by 
outgrowth from meniscal tissue, exhibited migration with similar behavior between inner and 
outer single channel controls. In the presence of HUVECs, bMFCs exhibited dose-dependent 
increases in migration over seven days in culture (Figure 3.1c), with no differences observed 





Figure 3.1. Endothelial cells enhanced migration of meniscus cells in a dose-dependent manner. 
(a) Schematic of the micropatterned system with HUVECs (left; L) and meniscus (right; R) cells encapsulated in 
parallel channels. (b) Representative images of migrating meniscus cells (red) in co-culture with HUVECs 
(green; 3.5×106/mL) and as single channel controls at days 0 and 3. Dashed lines indicate the left edge of 
meniscus channels. Scale bar: 200 µm. (c) Migration of meniscus cells in the micropatterned three-
dimensional hydrogel system, with and without endothelial cells, at day 7. * p < 0.05 vs. 0; ** p < 0.05 vs. 0, 
3.5; n = 20-73. 
 
3.4.2. Endothelial cell-conditioned medium was sufficient to enhance meniscus cell migration 
Given the enhancement of bMFC migration in the presence of endothelial cells, our next step 
was to verify if these effects can be induced by using conditioned medium from HUVEC 
monolayer expansion alone, indicative of paracrine signaling. After culture in a 1:1 mixture of 
HUVEC-conditioned medium and EGM-2, inner and outer cells again exhibited enhanced 
migration, similar to that observed in the presence of HUVECs, demonstrating that migration 
was induced by paracrine factors secreted into culture medium (Figure 3.2a). In order to 
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identify these factors, human angiogenesis arrays were performed on EGM-2 and HUVEC-
conditioned medium (Figure 3.2b), and three angiogenic factors of interest were identified: 
endothelin-1 (ET-1), PDGF, and VEGF (Figure 3.2c). We chose to study the PDGF-BB isoform, 
because of its specific role in angiogenesis134. 
 
In order to quantify the presence of these factors in our co-culture system, we collected media 
over seven days from bMFCs with and without HUVECs, and measured the concentrations of 
ET-1, PDGF-BB, and VEGF, compared to EGM-2 (Figure 3.2d). These values correspond to the 
difference between initial concentrations in EGM-2 and production by HUVECs, and 
subsequent consumption by bMFCs and HUVECs. ET-1 and PDGF-BB were not detectable in 
EGM-2, and very low or not detectable in controls without HUVECs at day 7. However, in co-
culture samples, their levels were significantly higher than in controls. Notably, the 
concentration of PDGF-BB in co-culture of inner cells was significantly greater than in co-
culture of outer cells, suggesting differential interaction of PDGF-BB with inner versus outer 
cells, whereas ET-1 levels were consistent across co-culture of inner versus outer cells, 
suggesting similar action on both cell types. In contrast, VEGF is a known supplement in EGM-
2 with high initial concentration, and decreases after seven days without significant variation 





Figure 3.2. HUVEC-conditioned medium was sufficient to enhance meniscus cell migration. 
(a) Migration of meniscus cells (single channels only) with and without HUVEC-conditioned medium at day 7. * 
p < 0.05 vs. –; n = 64-130. (b) Representative images of human angiogenesis protein arrays for EGM-2 and 
conditioned medium after HUVEC expansion in monolayer (HUVEC). Boxes indicate positive reference spots. (c) 
Fold change of mean pixel density vs. positive reference in human angiogenesis arrays for EGM-2 (n = 1); 
HUVEC-conditioned medium (n = 3). (d) Concentration of endothelin-1 (* p < 0.05 vs. 0), PDGF-BB (* p < 0.05 
vs. inner 0, outer 3.5; ** p < 0.05 vs. outer 0), and VEGF (* p < 0.05 vs. all) in EGM-2 (day 0) and media 
collected from meniscus cells with and without endothelial cell co-culture over 7 days. n = 3-5; # n = 2 
detectable measurements out of 4 tested samples; n.d.: not detected. 
 
3.4.3. Differential effects of paracrine signaling on migration of meniscus cells from the inner and outer 
region  
Next, we probed the paracrine mechanisms of HUVECs on bMFC migration by studying the 
(1) dose-dependent supplementation of angiogenic factors to bMFCs only, (2) inhibition of 
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factors by neutralizing antibodies in co-culture, and (3) inhibition of corresponding bMFC 
receptors by antagonists in co-culture. 
 
First, we investigated ET-1/ETAR signaling, by supplementing ET-1 to single channels of inner 
or outer bMFCs only. Both cell types responded to ET-1 with dose-dependent increases in 
migration (Figure 3.3a). Inhibition of ET-1/ETAR signaling by blocking ET-1 activity via 
neutralizing antibody (Ab) or ETAR function via receptor antagonist (I) yielded similar 
decreases in inner and outer cell migration in co-culture. In contrast, for PDGF/PDGFR 
signaling, outer cells showed dose-dependent motility increases in response to PDGF-BB 
(Figure 3.3b), but not inner cells. Likewise, inhibition of PDGF-BB or PDGFRα/β yielded 
significant decreases in migration of outer cells, but not of inner cells. While VEGF also 
enhanced dose-dependent migration of inner and outer cells (Figure 3.3c), inhibiting VEGF or 
VEGFR1/2 did not significantly affect migration. These results are consistent with angiogenic 
factor levels in media (Figure 3.2c): ET-1 influences inner and outer cells, PDGF-BB on outer 





Figure 3.3. Effects of paracrine signaling by endothelial cells on migration of cells from the inner and outer 
regions. 
Migration distances of meniscus cells are shown at day 7 following: (a) ET-1 supplementation (single channels 
only). * p < 0.05 vs. 0; ** p < 0.05 vs. 0, 10; n  = 62-182. Neutralizing antibody against ET-1 (Ab). * p < 0.05 vs. 
0, 3.5 + Ab, 10; n  = 24-87. ETAR antagonist (I). * p < 0.05 vs. 0, 3.5 + I; n  = 30-87. (b) PDGF-BB 
supplementation. * p < 0.05 vs. 0; ** p < 0.05 vs. 0, 10; n = 21-84. Neutralizing antibody against PDGF-BB. * p 
< 0.05 vs. 0, 3.5 + Ab, 10; n  = 17-78. PDGFRα/β antagonist. * p < 0.05 vs. 0, 3.5 + Ab, 10; n  = 25-88. (c) 
VEGF165 supplementation. * p < 0.05 vs. 0; ** p < 0.05 vs. 0, 10; n  = 20-118. Neutralizing antibody against 
VEGF-A. * p < 0.05 vs. 0; n = 34-81. VEGFR1/2 (Flt1/KDR) antagonist. * p < 0.05 vs. 0; n = 46-83. 
 
3.4.4. Meniscus cells exhibited differential expression of receptors in co-culture with HUVECs 
At the gene level, we quantified the expression of receptors in bMFCs with and without 
HUVEC co-culture. Fold change in expression of EDNRA, encoding ETAR, was significantly 
upregulated in inner and outer cells with co-culture, compared to controls (Figure 3.4a). In 
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contrast, co-culture of outer cells increased expression of PDGFRA (PDGFRα) and PDGFRB 
(PDGFRβ), compared to inner cells under the same conditions (Figure 3.4b). Finally, fold 
change of FLT1 (Flt1/VEGFR1), did not vary significantly among bMFCs with and without 
HUVECs (Figure 3.4c). The relative expression of KDR (KDR/VEGFR2) was minimal at day 0 
(inner: 3.70×10-5 ± 8.64×10-6; outer: 1.82×10-5 ± 5.01×10-6; n = 4-6). However, trends in relative KDR 
expression at day 7 were similar to that of FLT1 (Figure 3.4d). 
 
 
Figure 3.4. Co-culture with endothelial cells differentially regulated expression of receptor genes in meniscus 
cells. 
Fold change (2-ΔΔCT) in gene expression of meniscus cells at day 7, with and without endothelial cells, relative to 
cells at day 0, both normalized to GAPDH, for (a) EDNRA, encoding endothelin receptor type A. * p < 0.05 vs. 0; 
n = 3-4. (b) PDGFRA and PDGFRB, encoding PDGF receptors α and β. * p < 0.05 vs. 0; n = 3-7. (c) FLT1, 
encoding Flt1 (VEGF receptor 1). n = 4-6. (d) Relative gene expression (2-ΔCT) of meniscus cells at day 7, with 
and without endothelial cells, normalized to GAPDH, for KDR, encoding KDR (VEGF receptor 2). Relative gene 
expression (2-ΔCT) of meniscus cells at day 0, normalized to GAPDH, was 3.70×10-5 ± 8.64×10-6 for inner cells, 
and 1.82×10-5 ± 5.01×10-6 for outer cells. n = 4-6. 
 
Regional variation in expression of EDNRA, PDGFRA, and PDGFRB were consistent at the 
protein level (Figure 3.5). First, HUVEC phenotype was verified by von Willebrand Factor 
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(vWF) staining. In single channel controls, staining for ETAR, PDGFRα, and PDGFRβ were 
either below detection level or negative, whereas bMFCs in co-culture exhibited differential 
staining profiles: outer cells were positive for ETAR, PDGFRα, and PDGFRβ, but inner cells 
appeared positive for ETAR only. Overall, both the ET-1/ETAR and PDGF/PDGFR signaling 
pathways activated outer cells, but inner cells responded to ET-1/ETAR only. 
 
Positive staining of Ki-67, a marker for proliferating cells, was not dramatically different 
between bMFCS with and without HUVECs after seven days of culture, suggesting that cell 
proliferation did not significantly contribute to migration phenomena. 
 
 
Figure 3.5. Regional variation of receptor activation in migrating meniscus cells with endothelial cell co-culture. 
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Immunofluorescence staining of HUVECs at day 7, against DAPI and von Willebrand factor (vWF), and in 
meniscus cells, against DAPI, ETAR, PDGFRα, PDGFRβ, and Ki-67 for proliferating cells. In co-culture with 
HUVECs, outer cells exhibit positive staining for ETAR, PDGFRα, and PDGFRβ, while inner cells exhibit positive 
staining for ETAR only, consistent with regional variation at the gene expression level. Proliferation was not 
different between inner and outer cells, either in the presence or absence of endothelial cells. Arrows indicate 
the left edge of meniscus channels. Scale bar: 200 µm. 
 
3.4.5. Endothelin-1 enhanced meniscus cell migration and proliferation in an explant model of integrative 
repair  
Since inner and outer cells responded to ET-1 at the micro-scale, we examined the macro-scale 
repair response of meniscal explants to ET-1, using a full-thickness defect model. Over four 
weeks of continuous ET-1 supplementation, explants from the inner and outer regions 
demonstrated modest but significant increases in integration strength compared to controls 
without ET-1 (Figure 3.6a). The similarity in integration strength between inner and outer 
explants was consistent with previous studies in which explants from both regions exhibited 
comparable healing in vitro62, in contrast to the regional differences seen in vivo. At day 14, the 
total DNA content of outer explants with ET-1 exceeded that of outer explants without ET-1, 
and by day 28, the DNA content of inner and outer explants with ET-1 was significantly 
greater than controls. Notably, the initial DNA content of outer explants was significantly 
greater than inner explants at day 0, which correlates with the increased cellularity observed in 
the outer region relative to the inner146. Although DNA content across all groups fell from 
initial values, H&E staining demonstrated superior cell accumulation at the defect interface of 
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explants treated with ET-1, versus controls, at day 28 (Figure 3.6b). Moreover, evidence of 
fraying collagen fibers was distinct in controls at day 28, compared to the defect appearance at 
day 0. 
 
Proliferating cells in explants were visualized again by Ki-67 staining (Figure 3.6c). For inner 
and outer explants, ET-1 treatment resulted in more intense and uniform staining than in 
controls. Staining was most prevalent in outer explants with ET-1, which can be expected, 
given that this group also contained the highest overall DNA content. 
 
Finally, increases in ETAR expression were observed at day 28 in inner and outer explants 
treated with ET-1 (Figure 3.6d). Curiously, positive ETAR staining was also present in both 
regions at day 0, which may explain the residual staining present in samples without treatment 






Figure 3.6. Mitogenic effects of endothelin-1 (ET-1) on integrative repair of meniscus. 
(a) Integration strength of the explant interface and total DNA content of explants over 28 days. * p < 0.05 vs. 
day 0 and day 28 ET-1–; ** p < 0.05 vs. day 28 ET-1–; *** p < 0.05 vs. day 14 ET-1–; # p < 0.01 vs. day 0 inner; 
n = 3-6. (b) Hematoxylin and eosin (H&E) staining at days 0 and 28. Arrows indicate the interface. Scale bar: 
50 µm. Immunofluorescence staining against DAPI and (c) Ki-67 for proliferating cells in explants at day 28, 
and (d) ETAR at days 0 and 28. Dashed lines indicate the interface. Scale bar: 200 µm. 
 
3.5. Discussion 
We demonstrate that fibrochondrocytes from the inner avascular and outer vascular regions of 
meniscus exhibit enhanced migration in the presence of endothelial cells, despite regional 
variation in vascularity. Although both cell types displayed similar behavior, migration of 
inner versus outer cells was differentially regulated by paracrine signals secreted by 
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endothelial cells. Endothelin-1 stimulated migration of inner and outer cells, and inhibition of 
ET-1/ETAR signaling suppressed the beneficial effects of endothelial cell co-culture. In contrast, 
PDGF-BB only promoted the migration of outer cells, with no action on inner cells. Finally, 
supplementation of VEGF-A promoted migration of both cell types in the absence of 
endothelial cells, but overall migration was unaffected by inhibition of VEGF/VEGFR activity 
during co-culture. 
 
A disparity between the contributions of VEGF-A to bMFC  migration, via co-culture with 
HUVECs or supplementation to culture medium, was evident by the absence of change in 
VEGFR1/2 gene expression upon co-culture with HUVECs. A possible explanation is that 
initial VEGF concentration in EGM-2 was significantly higher than VEGF production by 
HUVECs. Indeed, VEGFR1/2 gene expression was uniformly upregulated in all groups after 
culture in EGM-2, relative to the starting bMFC populations. Given the dramatic decrease in 
VEGF from EGM-2 to HUVEC-conditioned medium, it could be further surmised that 
HUVEC consumption of VEGF was greater than its production. Moreover, the concentration 
of VEGF in EGM-2 was lower than in the VEGF-supplemented medium, which resulted in 
dose-dependent increases in bMFC migration. Therefore, the contribution of VEGF produced 
by HUVECs to bMFC migration may be small compared to that of supplemented VEGF. This 
observation is consistent with experimentally induced meniscal injury in vivo, in which 
elevated VEGF protein was expressed in the avascular region, but neither angiogenesis nor 
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healing were observed137. Furthermore, the direct, local application of VEGF to stimulate 
angiogenesis in the avascular zone did not promote healing in vivo 147,148. While VEGF has an 
essential role in regulating angiogenesis, its contribution to meniscal repair appears secondary, 
and may require the presence of additional angiogenic factors for healing in vivo.  
 
In contrast, PDGF-BB differentially regulated bMFCs from the inner and outer regions of the 
meniscus. Outer cells showed dose-dependent increases in migration with PDGF-BB and 
decreased migration with inhibition of its activity, whereas migration of inner cells did not 
change with PDGF-BB supplementation or inhibition. Moreover, PDGF receptor expression 
was upregulated in co-culture with outer cells, but not inner. This regional variation in 
response to PDGF-BB suggests that outer cells are stimulated by PDGF secreted by endothelial 
cells present in the region, while inner cells from the avascular region are not. Our findings are 
consistent with previous reports that PDGF-AB stimulated the mitogenic response of explants 
from the vascular region, but not from the avascular region149. In another study, PDGF-AB 
promoted cell proliferation and matrix synthesis in 3-D cell pellets from both regions, but outer 
cells demonstrated a more potent response to PDGF-AB supplementation150. However, bMFCs 
from the inner and outer regions were also found to respond to PDGF-AB with enhanced cell 
proliferation and 2-D migration, but only over short durations of two days and four hours, 
respectively138. The same team demonstrated that controlled release of PDGF-AB also 
enhanced cell migration and proliferation in full-thickness defects of avascular explants, but 
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only within the first 3-7 days, with no significant differences remaining by the end of the four 
week study151. In vitro explant studies in which regional variation was not specifically taken 
into account reported increased proteoglycan synthesis in the presence of PDGF-AB152,153. In 
vivo, positive immunostaining for PDGF was detected in a model of avascular meniscal injury, 
after treatment by meniscal rasping to increase the vascular response to the region56. These 
diverse effects of PDGF in various meniscus models suggest its potential utility in enhancing 
repair, but also the need for coupling the action of PDGF to other angiogenic factors for 
optimal healing. 
 
We identified endothelin-1 as an angiogenic factor governing the behavior of cells from the 
inner and outer regions of the meniscus, both at the micro-scale in patterned hydrogel-
encapsulated cells, and the macro-scale in an explant model of meniscal injury. Unlike PDGF-
BB, which preferentially stimulated the migration of outer cells, ET-1 produced similar 
migration responses between inner and outer cells, and similar changes between both cell 
types with inhibition of its signaling pathway. In a full-thickness defect model of meniscal 
repair, ET-1 enhanced total cell proliferation, as well as cell accumulation at the defect interface, 
contributing to overall increases in integration strength. Although endothelin-1 has not been 
previously studied in the context of the meniscus, ET-1 and associated receptor signaling have 




However, the effects of ET-1 on cartilage are not always positive. Angiogenesis is also a 
recognized component of OA154, and a catabolic role for ET-1 has been suggested in studies of 
human osteoarthritic cartilage155. Likewise, ETAR antagonists have been shown to prevent joint 
degradation in a surgically induced rat model of OA156. Arguably, these observations pertain to 
the inflammatory conditions during natural and experimental OA, in which physiological 
tissue remodeling has been irreversibly shifted away from synthesis, and towards 
degradation157.  Since the meniscal etiology of OA implies injury before the presentation and 
progression of disease, there is a timeframe during which meniscus-specific interventions can 
occur. This timeframe, following meniscal injury but preceding the onset of OA, corresponds 
with a tissue environment in which a balance between degradation and synthesis could be re-
established.  
 
We propose a novel strategy for enhancing cell proliferation at the site of a meniscal injury 
through application of endothelin-1. The bMFCs in our migration studies comprise a 
multipotential population that may contribute to endogenous repair42. These cells migrated in 
response to ET-1 in hydrogel, and accumulated at the defect interface in explants from both the 
inner and outer regions. We anticipate that ET-1 can instruct these endogenous repair cells to 
migrate to the site of meniscal injury in vivo. However, the explant model of meniscal repair 
revealed only modest increases in integration strength over time, without significant 
differences in sulfated GAG or hydroxyproline content between ET-1-treated and non-treated 
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samples after four weeks of culture. Therefore, application of ET-1 in concert with TGF-β3, 
known to enhance meniscal repair in vitro121, merits additional inquiry. Moreover, we can 
further elucidate ET-1’s role in a pro-inflammatory environment by combining ET-1 with TNF-
α or IL-1, inflammatory cytokines that have been previously studied in meniscal repair158. By 
examining the effects of ET-1 under pro-anabolic or pro-catabolic conditions, with continuous 
supplementation as described in this study, or transient application to induce cellular 
accumulation at the defect, and then fibrochondrogenesis, we can obtain a more thorough 
understanding of its role in meniscal healing. 
 
In summary, vascularity directly impacts meniscal repair, with endothelial cells enhancing 
migration of inner and outer cells via distinct mechanisms. We identify ET-1 as a relevant and 
previously unstudied angiogenic factor in the meniscus, which stimulates cell migration and 
repair in both the avascular and vascular regions. Further exploration into the contribution of 
ET-1 to meniscal repair may yield an alternative to partial meniscectomy in patients with 
avascular meniscal injuries, and prevent OA development in the long term.  
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Chapter 4. Electrical stimulation enhances cell migration and integrative repair in the 
meniscus 
4.1. Abstract 
Electrical signals have been applied towards the repair of articular tissues in the laboratory and 
clinical settings for over seventy years. We focus on healing of the meniscus, a tissue essential 
to knee function with limited innate repair potential, which has been largely unexplored in the 
context of electrical stimulation. Here we demonstrate for the first time that electrical 
stimulation enhances meniscus cell migration and integrative tissue repair. We optimize 
pulsatile direct current electrical stimulation parameters on cells at the micro-scale, and apply 
these to healing of full-thickness defects in explants at the macro-scale. We report increased 
expression of the adenosine A2b receptor in meniscus cells after stimulation at the micro- and 
macro-scale, and propose a role for A2bR in meniscus electrotransduction. Taken together, these 
findings advance our understanding of the effects of electrical signals and their mechanisms of 
action, and contribute to developing electrotherapeutic strategies for meniscus repair. 
 
4.2. Introduction 
Electric fields are known to guide the development and regeneration of many tissues, 
including cartilage75–77. However, the exact roles of electrical signals in regulating the 
biosynthetic activity and homeostasis of articular tissues remain elusive, although preclinical 
and clinical studies have demonstrated superior healing following their application88–90. The 
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meniscus is of particular interest, as knee arthroscopy for meniscus intervention is the most 
performed procedure by orthopaedic surgeons159. In the past, the entire meniscus was 
routinely removed by total meniscectomy, but long-term outcomes have since demonstrated 
that the incidence and severity of osteoarthritis is proportional to the amount of tissue removed 
127. Moreover, the extent of intrinsic repair after surgery is largely determined by the location of 
the injury: while meniscus tears in the outer vascular tissue region can undergo repair, those in 
the inner avascular region do not9. This regional variation has led to novel approaches to 
overcome the limited healing potential of injuries in the inner meniscus. 
 
The biochemical composition of the meniscus also varies by region, with predominantly type I 
collagen in the more fibrous outer region, and a mixture of types I and II collagen in the more 
cartilaginous inner region37. The bulk of the remaining extracellular matrix (ECM) is composed 
of negatively charged glycosaminoglycans (GAGs)39, which  hydrate the tissue, contribute to its 
compressive properties, and also allow for electrical activity40. After meniscus injury, increases 
in GAG levels in the synovial fluid peak early, and persist out to four years after injury160. The 
synovial environment after injury also has elevated levels of IL-1 and TNF-α46–48, which act in 
concert to increase the production of nitric oxide (NO), prostaglandin E2 (PGE2), and matrix 
metalloproteinases (MMPs), increase the release of GAGs, and decrease the synthesis of 
collagen in the meniscus49,50,54. The full-thickness defect model in explants has been employed 
extensively in the study of meniscus repair in the presence of IL-1 and TNF-α, demonstrating 
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dose-dependent decreases in integration strength and tissue repair over sustained 
supplementation161, and long-term potentiation of effects even after acute exposure162. The 
application of dynamic loading on meniscus explants in the presence of IL-1 was found in turn 
to combat the cytokine’s inflammatory effects on integrative repair163. 
 
The endogenous electrical potentials during physiological loading of articular cartilage have 
been studied using theoretical78–80 and experimental81,83,84 models, and these native electrical 
signals have been implicated in transducing mechanical signals to cells within tissues81,86,87. A 
variety of electrical stimulation modalities investigated in 2-D and 3-D models of cartilage in 
vitro and cartilage repair in vivo 88–90 were shown to significantly increase cell proliferation91,92 
and GAG synthesis93,94, upregulate the expression of ECM genes95, and reduce the production 
of inflammatory mediators such as IL-1 and MMPs96. However, questions remain as to how 
electrical signals influence cells and propagate their effects. The adenosine receptors have been 
implicated in the electrotransduction of pulsed electromagnetic fields in cartilage114,115. 
Stimulation of the high-affinity A2a and low-affinity A2b adenosine receptors resulted in 
elevated cyclic AMP103 and subsequent activation of anti-inflammatory pathways via protein 
kinase A and EPAC, which in turn lead to the suppression of NO and PGE2104 and downstream 
feedback inhibition of TNF-α and IL-1β105. We therefore hypothesized that electrical 
stimulation will enhance repair of the meniscus and control the inflammatory events 
underlying tissue degradation. 
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Given the wealth of background information on electrical stimulation, inflammation, and 
adenosine receptor signaling in cartilage repair, it may come as a surprise that very little 
published information exists in the context of the meniscus. Only recently, meniscus cells from 
the outer region were found to migrate more quickly in 2-D culture than inner cells, in the 
presence of static direct current (DC) fields164. However, electrical stimulation studies have 
demonstrated a disparity in migration behavior between 2-D and more physiologically 
relevant 3-D environments165. Moreover, pulsatile electric fields (EFs) are already used in the 
clinical setting for related conditions99,100. At this time, the effects of applied EFs on meniscus 
cells and subsequent development of novel repair strategies are only beginning to be 
understood. We investigated the effects of pulsatile direct current electric field stimulation on 
meniscus cell migration in a micropatterned 3-D hydrogel system. Our micro-scale system also 
enabled study of the paracrine signaling between meniscus and endothelial cells, in concert 
with electrical stimulation. Rigorous screening and optimization of stimulation parameters at 
the micro-scale enabled the identification of potential pathways involved in 
electrotransduction. By translating from the micro- to the macro-scale, we established 
stimulation regimes that enhanced integrative repair of full-thickness defects in meniscus, and 




4.3. Materials and Methods 
4.3.1. Cell isolation 
Juvenile bovine meniscus cells were isolated from the inner and outer regions as previously 
described42. Briefly, the menisci of calves were dissected within 36 h of slaughter (Green Village 
Packing Company), and sectioned into inner (2/3) and outer (1/3) regions. The tissue was then 
minced into 1-2 mm3 pieces, and plated on tissue culture plates in basal medium consisting of 
high glucose DMEM, 1× antibiotic-antimycotic, 10% FBS, and 50 µg/mL ascorbate 2-phosphate. 
Over 2-3 weeks, cells migrated out of the tissue pieces, and were expanded to passage 2. 
Human umbilical vein endothelial cells (HUVECs) were isolated from fresh umbilical cords of 
term delivery, collected according to an active IRB at Columbia University142. Umbilical cords 
were rinsed with PBS, and the umbilical vein lumen was infused with a 2.5% trypsin solution 
and clamped at both ends. Enzymatic digestion occurred at 37°C for 15 min, and the resulting 
cell digest was collected by rinsing the vein with PBS and centrifugation at 300×g for 5 min. The 
cell pellet was resuspended on 25 cm2 tissue culture flasks in endothelial growth medium 
(EGM-2; Lonza), and expanded to passage 5. 
 
4.3.2. Explant culture  
Juvenile bovine meniscus explants were harvested from the central tissue region using sterile 4 
mm Ø biopsy punches, and cut to 1.5 mm height using a custom microtome device. A 1.5 mm 
Ø central core was punched and immediately replaced into the explant ring to simulate a full-
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thickness defect. Explants were cultured for 3 days in basal medium prior to the start of each 
experiment. 
 
4.3.3. Cell migration assay 
The micropatterned three-dimensional hydrogel system used in cell migration studies was 
previously established for the study of human mesenchymal stem cells and HUVECs in co-
culture142. Briefly, the poly(dimethylsiloxane) (PDMS; 9:1 elastomer:curing agent; Sylgard 184 
silicone elastomer kit, Dow Corning) micropattern consisted of two parallel channels (1 cm 
length, 1000 μm width, 200 μm height, channel-to-channel distance: 2000 μm; Figure 4.1b). 
Prior to cell encapsulation, the PDMS surface was blocked using a 5% solution of FBS in sterile 
distilled water. 
 
In single channel studies (Figure 4.1a), inner or outer meniscus cells were encapsulated at 
3.5×106 cells/mL each in 1.8% fibrin (bovine fibrinogen, MP Biomedicals; thrombin from bovine 
plasma, Sigma-Aldrich) and printed into single channels on plastic slides. The cell-fibrin 
suspension was allowed to polymerize for 15 min, before removal of the PDMS mold and 
encapsulation in an additional layer of 1.8% fibrin to permit cell migration. In co-culture 
studies (Figure 4.1b), inner or outer meniscus cells and HUVECs were encapsulated at 3.5×106 
cells/mL each in 1.8% fibrin, printed into two parallel channels on plastic slides, and covered by 
another layer of 1.8% fibrin. Single channels of inner or outer meniscus cells served as controls. 
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Cultures were maintained in EGM-2 over 6 days after encapsulation, and migration was 
monitored by bright field imaging at days 0 and 6, using an Olympus IX81 microscope with an 
IX2-UCB digital camera and Metamorph software. 
 
4.3.4. Electrical stimulation of cells 
After 3 days of pre-culture without stimulation, the cells were transferred into custom 
bioreactors with carbon electrodes (Ladd Research Industries) spaced 2.5 cm apart (Figure 
4.1a)166. Bioreactors were connected by platinum wire to an electrical stimulator (Grass 
Technologies) generating continuous pulses of 7.5 V, corresponding to a field strength of 3 
V/cm,  and various frequency and pulse duration combinations (0.1, 1, 10 Hz and 2 ms pulse 
duration; 10 Hz and 0.2 ms pulse duration)  for 3 days. Bioreactors not connected to the 
stimulator served as controls (0 V). 
 
4.3.5. Electrical stimulation of explants 
After 3 days of pre-culture, explants were stimulated in a custom bioreactor (Figure 4.1c), 
consisting of a 5×6 array outfitted with carbon electrodes that were spaced 1 cm apart, and 
connected directly to a stimulator generating pulses of 3 V, corresponding to a field strength of 
3 V/cm, and either 1 Hz and 2 ms pulse duration or 10 Hz and 0.2 ms pulse duration. Each row 
was independently stimulated, with six wells per row receiving the same stimulation regime. 
Rows not connected to the stimulator served as controls (0 V).  Explants were stimulated four 
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days a week over six weeks of culture in basal medium, with media collection at each change, 
and sample collection for mechanical integration testing, biochemical assays, and histological 
and immunofluorescence staining at biweekly time points.  
 
 
Figure 4.1. Electrical stimulation of meniscus. 
(a) Optimization of electrical stimulation parameters in a micropatterned 3-D hydrogel system for cell 
migration. Inner or outer meniscus cells were encapsulated on plastic slides in a 1.8% fibrin channel (3.5×106 
cells/mL) and covered by a second layer of 1.8% fibrin to enable migration. After 3 days of pre-culture, slides 
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were transferred into custom bioreactors with carbon electrodes spaced 2.5 cm apart, for 3 days of 
stimulation. (b) Co-culture of meniscus cells with endothelial cells. Human umbilical vein endothelial cells 
(HUVECs) and inner or outer meniscus cells (3.5×106 cells/mL) were individually encapsulated on slides in 
parallel fibrin channels, left and right, respectively, and cultured for 3 days of pre-culture and 3 days of 
stimulation. (c) Juvenile bovine meniscus explants were punched with central cores of 1.5 mm diameter and 
immediately replaced to simulate a full-thickness defect. Explants were stimulated four days a week over six 
weeks of culture in a custom bioreactor system, consisting of a 5×6 array with carbon electrodes spaced 1 cm 
apart. 
 
4.3.6. Evaluation of meniscus cell migration 
Bright field images were processed using a custom MATLAB program144 to track cell 
migration. Briefly, the program applied the Sobel edge detection algorithm and eliminated 
small regions of isolated, single meniscus cells. Each image was evenly subdivided into regions 
corresponding to ~1580 µm of the channel length, for which average channel-to-channel 
distances were calculated. 
 
4.3.7. Real-time PCR  
The total RNA of meniscus cells or HUVECs after six days of culture was extracted by TRIzol 
reagent (Invitrogen) and reverse transcribed (High Capacity cDNA Reverse Transcription Kit, 
Applied Biosystems). Meniscus cells and HUVECs were also collected at day 0 prior to 
encapsulation and processed to facilitate fold change analysis (2-ΔΔCT). Real-time PCR was 
performed on an Applied Biosystems StepOnePlus Real-Time PCR System using Fast SYBR 
Green Master Mix (Invitrogen), custom bovine primers for COL1A2, EDNRA, PDGFRA, 
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PDGFRB, ADORA1, ADORA2A, ADORA2B, ADORA3, and GAPDH, and custom human 
primers for EDN1, PDGFA, PDGFB, and GAPDH.  
 
4.3.8. Mechanical integration testing of explants 
The integration of full-thickness defects in explants was tested with a custom device consisting 
of a 1.33 mm Ø indenter in series with a 50 g load cell, placed above a cup with a 2 mm Ø hole. 
Prior to testing, the height of each sample was measured using a digital caliper. The indenter 
was displaced at a ramp rate of 0.3% of the sample height per second, until the central core was 
pushed fully through the outer ring. Integration strength was calculated as the ratio of the peak 
force to the surface area of contact between the central core and outer ring. After testing, 
samples were collected for further biochemical analysis. 
 
4.3.9. Biochemical analysis of explants and media 
The biochemical composition of explants was evaluated for DNA, sulfated GAG, and OHP 
content. Briefly, samples were lyophilized for 24 h and digested at 60°C for 16 h in a papain 
solution containing 125 µg/mL papain (Sigma-Aldrich), 50 mmol phosphate buffer (pH 6.5), 
and 2 mmol N-acetyl cysteine (Sigma-Aldrich). DNA content of the sample digests was 
obtained using the PicoGreen dsDNA quantitation kit (Invitrogen), according to 
manufacturer’s protocol. Sulfated GAG content was measured using the 1,9-
dimethylmethylene blue dye-binding (DMMB) assay167. Hydroxyproline (OHP) content was 
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quantified by a modified acid hydrolysis assay168. Media collected at each change was assayed 
for TNF-α, IL-1β, and NO production, MMP activity, and GAG release using the DMMB 
assay. Briefly, TNF-α and IL-1β production were quantified directly on media samples using 
the bovine TNF-α (GenWay Biotech) and IL-1β (Thermo Fisher Scientific) ELISA kits, 
respectively. Prior to NO analysis, media samples were filtered through Vivaspin 500 units 
(10,000 MWCO PES filters, Sartorius), and total NO production in media samples was 
determined by quantification of nitrate and nitrite, according to manufacturer’s protocol 
(nitrate/nitrite colorimetric assay kit, Cayman Chemical Company). The activity of MMP-1, -2, -
3, -9, -13, and -14 was assessed via cleavage of a fluorescent peptide substrate (PEPDAB008, 
BioZyme), adapted from a previously published protocol169. Media samples were incubated in 
either 2.5 mM p-aminophenylmercuric acetate (APMA; pH 7.0-7.5) in assay buffer (200 mM 
NaCl, 50 mM Tris, 5 mM CaCl2, 10 μM ZnSO4, 0.01% Brij 35, pH 7.5) or in assay buffer alone at 
37°C for 5 h. Samples were then diluted twofold with assay buffer containing 20 μM substrate 
at 37°C for 2 h, and measured at 485 nm excitation and 530 nm emission. Total MMP activity 
was calculated as the difference in fluorescence readings between samples incubated with and 
without APMA.  
 
4.3.10. 5-bromo-2-deoxyuridine labeling of cells and explants 
At the endpoint of both migration and integration studies, samples were labeled with 5-
bromo-2-deoxyuridine (BrdU, Invitrogen) to assess cellular proliferation. Single channel 
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studies of meniscus cells were incubated with BrdU labeling reagent (1:50) at 37°C for 4 h, and 
explants (1:50) at 37°C overnight. Samples were then fixed for further histological processing. 
 
4.3.11. Histological and immunofluorescence staining of cells and explants 
Cell migration samples were fixed in a graded series of formaldehyde from 1% to 4% for 10 
min each, and maintained in PBS at 4°C until preparation for staining. Briefly, samples were 
blocked and permeabilized with agitation in PBS containing 5% BSA and 0.1% Triton X-100 at 
25°C for 1 h, and incubated at 4°C overnight with the primary antibody (rabbit anti-adenosine 
A2b receptor antibody, 50 μg/mL, Millipore) in PBS with 5% BSA. After 3 washes of 30 min each 
in PBS at 25°C with agitation, samples were incubated at 4°C overnight with Alexa Fluor® 555 
goat anti-rabbit IgG (1:200, Invitrogen) and DAPI (1:200, Invitrogen), followed by 3 additional 
washes. Alternatively, samples were directly incubated after blocking and permeabilization 
with DAPI and mouse anti-BrdU antibody (Alexa Fluor® 488 conjugate, 1:50, Invitrogen). 
 
Explants were fixed in 4% formaldehyde at 4°C overnight and embedded in 2% low-melting-
temperature agarose. All samples were dehydrated in a graded series of ethanol, embedded in 
paraffin, and sectioned to 8 μm thickness. Sections were stained with hematoxylin and eosin 
(H&E) for nuclei and cytoplasmic elements, respectively, Alcian blue (pH 1.0) for sulfated 
GAGs, and Picrosirius red for collagens. For immunofluorescence staining of A2bR in paraffin-
embedded samples, antigen retrieval was performed with 10 mM citrate buffer (pH 6.0). 
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Blocking in PBS with 5% BSA, and primary and secondary antibody incubations in PBS with 
5% BSA were completed, as previously described. Immunohistochemical staining of BrdU was 
conducted, according to manufacturer’s protocol (BrdU staining kit, Invitrogen). Stained 
hydrogels and explants were imaged with an Olympus FSX100 microscope. 
 
4.3.12. Statistical analysis 
For cell migration studies, 1-way ANOVA with Tukey post tests or post tests for linear trend 
were performed with Prism (α = 0.05). For integration studies, 2-way ANOVA with Bonferroni 
post tests and 1-way ANOVA with post-hoc tests for linear trend were also performed with 
Prism. All data are presented as mean ± SEM. 
 
4.4. Results  
4.4.1. Electrical stimulation has differential effects on meniscus cell migration 
Electrical stimulation of the meniscus was investigated using three distinctly different yet 
related experimental model systems in which inner and outer meniscus cells or explants were 
subjected to pulsatile direct current electrical stimulation: (a) micropatterned three-dimensional 
hydrogels with encapsulated inner or outer meniscus cells, (b) micropatterned 3-D hydrogels 
with spatially distributed meniscus and endothelial cells, and (c) a macroscopic in vitro model 
of meniscus healing (Figure 4.1). When cultured in the micropatterned 3-D hydrogel system, 
meniscus cells migrated over six days of culture, with the stimulated cells demonstrating 
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enhanced migration relative to non-stimulated control cells (Figure 4.2a). Notably, both inner 
and outer meniscus cells exhibited similar increases in migration with applied electrical signals 
at 3 V/cm, 1 Hz, 2 ms pulse duration (Figure 4.2b), despite the variation in repair response 
between their respective tissue regions. When injected charge, or the total amount of charge 
delivered during one stimulus pulse, was maintained at a constant field strength of 3 V/cm, 
further increases in cell migration were gained as the frequency of stimulation increased to 10 
Hz and the pulse duration decreased to 0.2 ms (Figure 4.2c). The combinations of 3 V/cm, 0.1 
Hz, 20 ms pulse duration, and 3 V/cm, 100 Hz, 0.02 ms pulse duration were also tested, but the 
longer pulse duration associated with 0.1 Hz led to a more rounded, quiescent cell appearance 
rather than the spread-out, migrating cell phenotype seen at the channel edge. The increase in 
frequency to 100 Hz did not markedly improve the migration behavior of inner or outer 
meniscus cells, likely a result of too brief of a refractory period for cells to fully respond to 
subsequent stimulation pulses. 
 
No apparent difference in positive BrdU staining, indicative of cellular proliferation, was 
apparent between the inner and outer cells, with and without stimulation (Figure 4.2d), 
suggesting that differences in cell motility over six days of culture were not the result of 
proliferation only. Finally, type I collagen, a key ECM component throughout the meniscus, 
exhibited trends of elevated gene expression in both inner and outer cells when the frequency 





Figure 4.2. Electrical stimulation enhanced meniscus cell migration. 
(a) Representative images of inner meniscus cell migration in a micropatterned hydrogel system with (10 Hz) 
and without (0 V) electrical stimulation, before (day 0) and after 3 days of pre-culture and 3 days (day 6) of 
stimulation (3 V/cm, 10 Hz, 0.2 ms pulse duration) or no stimulation (0 V). Scale bar: 200 µm. (b) Optimization 
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of stimulation frequency. Parameters were held constant at 3 V/cm, 2 ms pulse duration, with varying 
frequency (0.1, 1, 10 Hz). Migration distances at day 6 demonstrated increases for inner and outer meniscus 
cells at 1 Hz versus cells without stimulation (0 V). * p < 0.05 vs. 0 V; n = 38-194. (c) Maintenance of charge 
injection. Field strength was held constant at 3 V/cm, with varying frequency and pulse duration. A higher 
frequency (10 Hz) and shorter pulse duration (0.2 ms) further enhanced inner and outer meniscus cell 
migration at day 6. * p < 0.05 vs. 0 V; ** p < 0.05 vs. 0 V, 1 Hz; n = 68-252. (d) Immunofluorescence staining of 
migrating inner and outer cells at day 6 with (3 V/cm, 10 Hz, 0.2 ms pulse duration) or without (0 V) 
stimulation, against BrdU for proliferating cells and DAPI for nuclei. No overt differences in cell proliferation 
were apparent between the cell types with and without stimulation. Scale bar: 200 μm. (e) Fold change (2-ΔΔCT) 
in gene expression of COL1A2 in meniscus cells at day 6 relative to cells at day 0, respectively, both 
normalized to GAPDH. Increasing frequency of stimulation with maintenance of injected charge (3 V/cm, 1 Hz, 
2 ms or 3 V/cm, 10 Hz, 0.2 ms pulse duration) led to upward trends in gene expression. * p < 0.05 for linear 
trend; n = 5-10. 
 
4.4.2. Cooperative action of electrical stimulation and endothelial cells on meniscus cell migration 
Co-culture with human umbilical vein endothelial cells (HUVECs) was investigated in the 
context of regional variation in healing between the inner and outer meniscus. Notably, 






Figure 4.3. Collaboration of electrical stimulation and endothelial cells on migration of inner meniscus cells. 
Representative images of inner meniscus cell migration in a micropatterned hydrogel system with and without 
co-culture with HUVECs, before (day 0) and after 3 days of pre-culture and 3 days (day 6) of stimulation (3 
V/cm, 10 Hz, 0.2 ms pulse duration) or no stimulation (0 V). The combination of HUVECs and electrical 
stimulation enhanced the migration of meniscus cells from both the inner avascular and outer vascular 
regions, more than either stimulus alone. Scale bar: 200 µm. 
 
Stimulating HUVECs alone in the hydrogel system led to increased expression of EDN1, 
PDGFA, and PDGFB genes (Figure 4.4a), which encode key angiogenic factors (endothelin-1, 
PDGF-A, B) that modulate the behaviors of chondrocytes139 and meniscus cells138, suggesting a 
dual role of electrical stimulation in upregulating angiogenic factors that specifically enhance 
meniscus cell migration, in addition to promoting cell migration in general. Although 
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meniscus cells alone exhibited greater migration in response to the 3 V/cm, 10 Hz, 0.2 ms pulse 
duration regime, meniscus cell migration in co-culture with HUVECs at 10 Hz stimulation was 
not significantly greater than without HUVECs at 10 Hz, but was significantly greater than in 
non-stimulated meniscus cells with HUVECs (Figure 4.4b).  
 
The cooperative action of stimulation and co-culture was observed in the 3 V/cm, 1 Hz, 2 ms 
pulse duration regime (Figure 4.4b), suggesting that frequency-dependent interactions 
between chemical and electrical stimuli require optimization for collaborative effects. In this 
system, the expression of angiogenic factors by HUVECs was upregulated dramatically with 
stimulation at 1 Hz as compared to non-stimulated controls, whereas the effect of increasing 
frequency from 1 to 10 Hz was much smaller (Figure 4.4a). These findings may account for the 
positive trends seen in meniscus cell migration with co-culture at 1 Hz stimulation that were 
not apparent at 10 Hz. 
 
Using the 1 Hz stimulation regime, gene expression profiles of the meniscus cells were further 
investigated to elucidate how stimulation and co-culture cooperate to enhance migration. As 
seen in cultures of meniscus cells with electrical stimulation alone, both inner and outer cells 
showed increases in COL1A2 expression in response to combined stimulation at 1 Hz and co-
culture with HUVECs (Figure 4.4c). Although inner and outer meniscus cells demonstrated 
similar migration behavior in co-culture with HUVECs, they do so in response to different 
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angiogenic factors secreted by endothelial cells, as seen at the gene expression level. Both types 
of cells responded to stimulation in co-culture with HUVECs by increased expression of 
EDNRA, encoding endothelin receptor type A (Figure 4.4c). However, outer cells responded to 
the secretion of PDGF isoforms by HUVECs with increased expression of PDGFRA and 
PDGFRB, encoding PDGF receptors α and β, while no such changes were detected for inner 
cells. These results demonstrate that electrical stimulation and endothelial cells collaborate to 
activate meniscus cell receptors at the gene expression level, suggesting potential synergy 







Figure 4.4. Cooperative action of electrical stimulation and endothelial cells on meniscus cell migration. 
(a) Fold change (2-ΔΔCT) in gene expression of EDN1, PDGFA, and PDGFB in HUVECs at day 6 relative to cells at 
day 0, respectively, both normalized to GAPDH. Increasing frequency of stimulation with maintenance of 
injected charge (3 V/cm, 1 Hz, 2 ms or 3 V/cm, 10 Hz, 0.2 ms pulse duration) led to upward trends in gene 
expression. * p < 0.05 for linear trend; n = 3-4. (b) Optimization of electrical stimulation parameters for co-
culture of HUVECs and meniscus cells. Meniscus cell migration with HUVECs and stimulation at 3 V/cm, 10 Hz, 
0.2 ms pulse duration (10 Hz) was greater than with HUVECs alone at day 6 (left). * p < 0.05 vs. + HUVEC; n = 
37-154. Meniscus cell migration with HUVECs and stimulation at 3 V/cm, 1 Hz, 2 ms pulse duration (1 Hz)  
demonstrated cooperative, upward trends with the addition of each stimulus at day 6 (right). * p < 0.05 for 
linear trend (analysis of groups indicated by the same letter); n = 24-194. (c) Fold change (2-ΔΔCT) in gene 
expression of COL1A2, EDNRA, PDGFRA, and PDGFRB in meniscus cells at day 6 relative to cells at day 0, 
respectively, both normalized to GAPDH. Increasing frequency of stimulation with maintenance of injected 
charge (3 V/cm, 1 Hz, 2 ms or 3 V/cm, 10 Hz, 0.2 ms pulse duration) led to upward trends in gene expression. 
* p < 0.05 for linear trend (analysis of groups indicated by the same letter); n = 3-10. 
 
4.4.3. Electrical stimulation enhanced integrative repair of meniscus explants  
Using a macroscopic in vitro model of meniscus healing, translation of the micro-scale findings 
to the macro-scale revealed a significant increase in the integration strength of full-thickness 
defects in explants stimulated at 3 V/cm, 10 Hz, 0.2 ms pulse duration, after six weeks of 
culture (Figure 4.5a). Stimulation at 1 Hz, 2 ms pulse duration initially corresponded to 
decreases in integration strength over the first four weeks of culture, but surpassed control 
conditions without stimulation by day 42, albeit to a lesser extent than stimulation at 10 Hz. 
The underlying basis for the enhanced integration strength of defects in explants stimulated at 
10 Hz was further explored by assaying for biochemical content and visualizing the 
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distribution of cells and ECM within the tissue. The overall biochemical content of explants 
without stimulation decreased throughout six weeks of culture, consistent with previous 
studies of explant stability in long-term culture, in the absence of growth factor 
supplementation121,170 (Figure 4.5b). However, the GAG and OHP content of explants 
stimulated at 10 Hz was not significantly different than at day 0, in comparison to explants 
without stimulation, which were significantly lower than initial values (Figure 4.5b). In 
general, stimulation led to significant upward trends in DNA and OHP content of explants 
after six weeks of culture, as compared to explants without stimulation (Figure 4.5b). 
 
Histological evaluation revealed that the defect interface appeared more closely apposed in 
explants stimulated at 10 Hz than in control explants (Figure 4.5c). Specifically, newly 
synthesized matrix was observed at the interface, containing sulfated GAGs and collagens, as 
evidenced by Alcian blue and Picrosirius red staining, respectively. BrdU labeling was 
performed to assess the effects of electrical stimulation on cell proliferation, yielding more 
BrdU-positive cells at the interface of stimulated explants, and indicating a moderate role of 
electrical stimulation in triggering cell proliferation in explants over long-term culture. Taken 
together, these data suggest that in addition to tissue repair, electrical stimulation acts to 





Figure 4.5. Electrical stimulation enhanced integrative repair and maintained the biochemical composition of 
explants. 
(a) Integration strength of full-thickness defects in meniscus explants over six weeks with (3 V/cm, 1 Hz, 2 ms 
or 3 V/cm, 10 Hz, 0.2 ms pulse duration) and without stimulation (0 V). By day 42, stimulation at 10 Hz 
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significantly promoted integrative repair versus explants without stimulation (0 V) and stimulated at 1 Hz. * p < 
0.05 vs. day 0, vs. 0 V and 1 Hz at day 42; n = 3-9. (b) Biochemical composition of meniscus explants over six 
weeks: total DNA, sulfated GAG, hydroxyproline (OHP). At day 42, stimulation corresponded to significant 
upward trends in DNA and OHP content of explants compared to controls (0 V). Stimulation at 10 Hz 
maintained GAG and OHP content relative to day 0, in comparison to no stimulation (0 V) and stimulation at 1 
Hz. * p < 0.05 vs. day 0; ** p < 0.04 for linear trend; n = 3-9. (c) Histological staining of meniscus explants at 
day 42: H&E for cell nuclei and cytoplasmic elements, BrdU for proliferating cells, Alcian blue for sulfated 
GAGs; Picrosirius red for collagens. The interface at the site of injury (arrows) appeared closely apposed with 
cells and newly synthesized matrix in explants stimulated at 10 Hz compared to no stimulation (0 V). 
Stimulated explants stained moderately more positive for BrdU+ nuclei, suggestive of enhanced cellular 
proliferation. Scale bar: 50 µm. 
 
4.4.4. Anti-inflammatory effects of electrical stimulation on meniscus explants 
Evaluation of the components from media collected throughout six weeks of culture revealed 
increases in endogenous TNF-α and IL-1β production by explants without stimulation, 
compared to those receiving stimulation at 3 V/cm, 10 Hz, 0.2 ms pulse duration, particularly 
within the first four weeks (Figure 4.6a,b). The elevated cytokine levels in explants without 
stimulation corresponded with changes in NO production (Figure 4.6c), MMP activity (Figure 
4.6d), and GAG release (Figure 4.6e), which were typical of catabolic degradation: in 
comparison to stimulated explants, greater NO production, MMP activity, and GAG release 
were detected in explants without stimulation, suggestive of an anti-inflammatory, anti-
catabolic, and stabilizing effect of electrical stimulation in long-term culture in vitro. These 
changes in explants without stimulation occurred early in culture, within the first three weeks, 
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Figure 4.6. Electrical stimulation reduced the degradation of explants in vitro. 
(a) TNF-α and (b) IL1-β production in media over 42 days. Lower levels of TNF-α and IL-1β in media collected 
from stimulated explants (3 V/cm, 10 Hz, 0.2 ms pulse duration) during the first four weeks of culture 
corresponded with decreased (c) NO production in media. a p < 0.05 vs. day 0; b p < 0.05 vs. 10 Hz; n = 3. (d) 
Cumulative MMP activity and (e) GAG release in media per week over 42 days. The downstream effects of 
decreased TNF-α and IL-1β in media collected from stimulated explants correlated with decreased MMP 




4.4.5. Adenosine A2b receptor plays a role in meniscus electrotransduction 
Adenosine receptors in meniscus were identified by gene expression analysis of migrating 
cells, with and without stimulation at 3 V/cm, 10 Hz, 0.2 ms pulse duration. In hydrogel-
encapsulated cells, the expression of ADORA1, ADORA2A, and ADORA3, encoding the 
adenosine A1, A2a, and A3 receptors, respectively, was minimal at day 0 (2-ΔCT << 10-4; n = 4) and 
at day 6 after culture, with and without stimulation (2-ΔCT << 10-5; n = 4), but ADORA2B 
encoding A2bR was upregulated in meniscus cells with electrical stimulation at 3 V/cm, 10 Hz, 
0.2 ms, as well as 3 V/cm, 1 Hz, 0.2 ms pulse duration (Figure 4.7a). Translation to the protein 
level was evident through immunofluorescence staining of migrating meniscus cells at day 6, 
against A2bR and DAPI for nuclei (Figure 4.7b). Cells receiving stimulation demonstrated 
strong, positive staining for A2bR, while cells without stimulation exhibited little or none, 
suggesting that the applied electrical signals may activate A2bR directly.  
 
At the macro-scale level, cells in stimulated explants also stained positively for A2bR, whereas 
those not receiving stimulation appeared negative (Figure 4.7c), lending further evidence to the 
potential relationship between electrical signals and activation of the adenosine A2b receptors in 
meniscus. Moreover, the consistency in protein expression from the micro- to macro-scale 
continues to support the use of micro-scale systems for evaluation of a broad range of electrical 






Figure 4.7. Putative role of adenosine A2b receptor in mediating electrical stimulation of meniscus. 
(a) Fold change (2-ΔΔCT) in gene expression of ADORA2B in meniscus cells at day 6 relative to cells at day 0, 
respectively, both normalized to GAPDH. The addition of electrical stimulation (3 V/cm, 1 Hz, 2 ms or 3 V/cm, 
10 Hz, 0.2 ms pulse duration) upregulated expression of the gene encoding the adenosine A2b receptor (A2bR). 
* p < 0.05 vs. 0 V; n = 3-4. (b) Immunofluorescence staining of migrating meniscus cells at day 6 with (3 V/cm, 
10 Hz, 0.2 ms pulse duration) and without (0 V) stimulation, against A2bR and DAPI for nuclei. Stimulated cells 
exhibited positive staining for A2bR, but not cells without stimulation. Arrows indicate the left edge of channels. 
Scale bar: 200 μm. (c) Immunofluorescence staining in meniscus explants at day 42 with (3 V/cm, 10 Hz, 0.2 
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ms pulse duration) and without electrical stimulation (0 V), of A2bR and nuclei. Cells in stimulated explants only 
exhibited positive staining for A2bR. Boxes (top) indicate the areas pertaining to high magnification images 
(bottom).  Scale bar: 50 μm. 
 
4.5. Discussion 
Electrical stimulation is a versatile treatment modality that has yet to be fully explored in the 
context of injuries to the meniscus, in which negatively charged glycosaminoglycans form the 
basis for endogenous electrical activity81,86,87. We demonstrate that pulsatile direct current 
electric fields enhance meniscus cell migration in a micropatterned hydrogel system, and the 
integrative repair of meniscus defects in an in vitro explant model of meniscus healing.  
 
In our 3-D systems, electrical stimulation alone induced similar migration behavior in cells 
isolated from both the inner and outer regions, whereas previous studies have shown that 
outer cells migrate more quickly than inner cells during 2-D galvanotaxis164. This disparity in 
observation may arise in part from the use of distinct cell populations within the meniscus 
between the two studies: cells isolated by tissue explant outgrowth in culture in the present 
study, versus cells isolated by release from tissue matrix via digestion in the galvanotaxis 
studies164. The inner and outer meniscus cells used in our study were previously characterized 
as a population capable of differentiating along multiple lineages, and may represent tissue-
specific stem cells contributing to endogenous repair42. These cells, by nature of their isolation 
via tissue outgrowth, exhibit a predisposition for migration, which may also account for the 
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level of motility observed in cells, even in the absence of electrical stimulation. As such, an 
enriched population of these cells after passaging may have led to a more robust response to 
exogenous electrical stimuli than a mixed population obtained by digestion in previous studies. 
In addition, the applied electric fields in the current study were perpendicular to the direction 
of cell migration, but no bias in polarity of movement was observed, in contrast to the cathodal 
migration of meniscus cells during 2-D galvanotaxis164. The observed behavior is consistent 
with studies of human fibroblasts on 3-D collagen gels in static DC fields, in which preferred 
movement occurred perpendicular to the axis of stimulation, but not towards a specific pole165. 
 
The fibrin hydrogel used in the micropatterned system represented a simple three-dimensional 
environment to observe meniscus cell migration phenomena. However, it does not begin to 
replicate the dense tissue matrix found in the native meniscus. Therefore, it was particularly 
encouraging to discover that the parameters optimized at the hydrogel level were applicable at 
the tissue level, inducing the migration of endogenous repair cells to the defect interface. 
However, migration at the tissue level also necessarily requires remodeling of the dense 
surrounding matrix to enable movement, which involves the interplay and balance of pro-
inflammatory cytokines and MMPs, and anti-inflammatory and anabolic factors. After 
meniscus injury, experimentally induced or clinically occurring, this balance is tilted in favor of 
pro-inflammatory, catabolic events, necessitating examination into interventions that can re-
initiate synthesis of key ECM components. It has been previously reported that meniscus 
78 
 
explants lose their biochemical properties, specifically, DNA121 and GAG121,170 content, over time 
in culture. In this study, a similar loss in DNA and GAG content was seen in explants without 
stimulation over six weeks, and in addition, we observed a significant loss of collagen content. 
Interestingly, the explants receiving the optimal stimulation regime maintained their 
biochemical composition, suggesting a stabilizing effect of electrical stimulation, moving the 
balance away from the destructive aspect of remodeling towards the constructive side. By 
applying the findings on the cellular micro-scale to the tissue macro-scale, an additional benefit 
of electrical stimulation was revealed, that it may counteract the natural degradation of explant 
tissue in vitro, in addition to mediating cell migration. 
 
In order to understand the basis of the in vitro degradation, the concentration of pro-
inflammatory cytokines, TNF-α and IL-1β, were measured in the media collected during 
explant culture. The fetal bovine serum used in culture medium contained baseline amounts of 
both cytokines, but it is notable that statistically significant differences existed between the 
levels of TNF-α and IL-1β in explant culture media, with and without stimulation, in the 
absence of exogenous supplementation of either cytokine or other pro-inflammatory 
mediators. In clinical observation, synovial fluid from patients who underwent arthroscopy for 
a meniscus tear contained between 35-85 pg/mL TNF-α, and 90-125 pg/mL IL-1β171. The level 
of TNF-α detected in this system was well above what was found in a pathological state of 
meniscus injury, but within the working range of exogenous supplementation in other studies 
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of meniscus repair161. In contrast, IL-1β was below both pathologic levels and the range used in 
other meniscus studies169. IL-1α levels were not measured in this study, but are relevant due to 
the differences in relative potency of IL-1α and β in porcine meniscus explants172. Moreover, the 
effects of TNF-α and IL-1 were not independent, and interplay between the two cytokines in 
activating pro-inflammatory pathways has been documented46–50,54. The lower levels of TNF-α 
and IL-1β in explants receiving the optimal stimulation regime suggest inhibitory effects of 
electrical stimulation on their production. In contrast, increases in these cytokines were 
observed in explants without stimulation, with corresponding increases in NO production, 
MMP activity, and subsequent GAG loss in media. These two observations correlate with 
previous findings demonstrating that inhibition of MMPs can significantly reduce GAG loss in 
culture170. The loss of explant stability in the absence of electrical stimulation, particularly in the 
first half of the culture period, corresponds with the observation that meniscus injury disrupts 
tissue homeostasis and initiates a series of events furthering degradation127,173–175. 
 
The migration and anti-inflammatory responses elicited by electrical stimulation occur via the 
activation of membrane receptors on meniscus cells. It has been previously postulated that 
electromagnetic fields can serve as first messengers in signaling towards tissue repair176. Based 
upon the findings in this study, a new model of electrotransduction in meniscus could be 
proposed: after meniscus injury, TNF-α and IL-1 levels are elevated, progressing toward 
further tissue degradation (Figure 4.8a). Within this environment, the application of pulsatile 
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DC electrical stimulation selectively activates the adenosine A2b receptor, producing the second 
messenger cAMP, which triggers anti-inflammatory pathways that reduce NO production, 




Figure 4.8. Proposed model of meniscus electrotransduction. 
(a) After meniscus injury, elevated levels of the pro-inflammatory cytokines, TNF-α and IL-1, lead to increases in 
nitric oxide (NO) production, matrix metalloproteinase (MMP) activity, GAG release, and overall tissue 
degradation. (b) Transduction of pulsatile direct current electrical signals (E) may occur by G protein-coupled 
adenosine A2b receptors on the meniscus cell membrane, which stimulate adenylyl cyclase via Gs and activate 
cyclic AMP. Increases in intracellular cAMP trigger anti-inflammatory pathways, which suppress NO production, 
MMP activity, and GAG release, and inhibit the initial cytokines. These downstream effects may prevent the 




The physiological role of low-affinity A2bR has been less characterized than the high-affinity 
A2aR, which has been studied extensively for anti-inflammatory activity in the context of 
osteoarthritis and rheumatoid arthritis177–179. However, activation of the A2bR, leading to 
elevated cAMP, has been shown to inhibit MMP-1 production in fibroblast-like synoviocytes 
from RA patients180, and in this study, we report for the first time in meniscus, among the class 
of adenosine receptors, the increased expression of A2bR following electrical stimulation at both 
the micro- and macro-scale. In order to fully elucidate the role of A2bR in meniscus 
electrotransduction, further experiments using receptor agonists and antagonists must be 
tested in meniscus defect models, with the addition of exogenous sources of pro-inflammatory 
cytokines to the system, and measurement of changes in adenylyl cyclase and cAMP levels. 
Moreover, cells and explants in this study were derived from juvenile bovine meniscus, 
requiring future studies using adult or even osteoarthritic tissue to confirm and extend 
findings. While growth factors were not supplemented to medium in this system, the addition 
of TGF-β3 alone121 or TGF-β1 in the presence of IL-1181 has been shown to significantly enhance 
meniscus repair, meriting the further study of any potential synergy between electrical and 
chemical stimuli. However, it should be noted that the reparative and protective effects of 
electrical stimulation alone, as shown in this study, are more immediately translatable to the 




The contribution of growth factors was explored at the micro-scale through the co-culture of 
endothelial cells, as a model of clinical methods that increase the vascular response to the inner 
region129,130, which does not naturally undergo repair. The combination of biophysical and 
biochemical stimuli via EFs and co-culture with HUVECs cooperatively enhanced the 
migration of meniscus cells in a 3-D environment. Despite the variation in vascularity of their 
respective tissue regions, inner and outer cells demonstrated trends of increased migration in 
the presence of both stimuli as compared to either stimulus alone. The cooperative effects of 
electrical signals and HUVECs appeared to result from the direct effects of electrical signals on 
HUVECs, by upregulating gene expression of angiogenic factors such as endothelin-1 and 
PDGF isoforms, previously shown to act on chondrocytes139 and meniscus cells138. Curiously, 
we observed a regional variation in expression of endothelin and PDGF receptors by meniscus 
cells in co-culture with HUVECs, which is now the focus of ongoing studies to examine the 
differential paracrine mechanisms of endothelial cells on the meniscus.  
 
In addition, we found that the coordinated action of EFs and HUVECs on meniscus cell 
migration was more apparent using a different set of stimulation parameters than for EFs 
alone. This observation, as well as the variation in migration response seen during initial 
optimization of parameters for meniscus cells only, is in line with previous theories that a 
window exists in which productive electrical stimulation occurs93, and parameters must be 
optimized for all relevant cell types within the system. Although it was not tested in this study, 
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the interaction of electrical stimulation and endothelial cells is pertinent at the tissue level as 
well, with implications for clinical and adjuvant therapies. However, in vitro models of 
meniscus repair cannot fully replicate the regional variation in vascular environment within 
the tissue and its influence on healing62. Experimentation in an animal model is the most 
suitable next step towards validation of electrical stimulation as a modality for treatment of 
meniscus injury. 
 
In summary, the effects of pulsatile electric field stimulation on meniscus repair were 
demonstrated for the first time. Optimization of electrical stimulation regimes for cell 
migration was achieved at the micro-scale with short-term experiments, and then applied at 
the macro-scale towards significant integrative repair of full-thickness defects in meniscus 
explants. In situ stimulation of explants revealed another role of electric fields in modulating 
inflammation and reducing tissue degradation. The dual functions of electrical stimulation in 
meniscus support its use in the clinical setting, after surgical intervention, to recruit cells for 
tissue repair and to prevent the matrix degradation that leads to osteoarthritis. Future 
establishment of therapeutic strategies, by testing stimulation regimes and translating to 





Chapter 5. Meniscus extracellular matrix hydrogel for stem cell-based tissue repair 
5.1. Abstract 
Meniscal repair is the preferred treatment for injuries to the fibrocartilaginous tissues, but due 
to their limited healing potential, removal of damaged tissue is more commonly performed, 
directly contributing to osteoarthritis. To improve the clinical outcome of repair, mesenchymal 
stem cells (MSCs) can differentiate and produce new tissue. We developed a protocol for 
decellularization and preparation of meniscus ECM into hydrogel for in situ delivery of MSCs. 
Our decellularized meniscus ECM (mECM) hydrogel contains specific components, such as 
collagen I and II, which instruct MSC fibrochondrogenesis. The growth and synthesis of new 
matrix by MSCs in mECM hydrogel was superior to that of cells in collagen I hydrogel alone, 
indicating the presence and significance of ECM components other than collagen I in directing 
MSC differentiation. We delivered MSCs in mECM hydrogel into a meniscal explant model of 
a full-thickness defect, and demonstrated significant integration over six weeks in vitro. 
However, phenotypic stability of the fibrocartilage varied after an additional four weeks of 
subcutaneous implantation, with mineralization detected in some explants. Our findings 
represent the first use of decellularized meniscus ECM for MSC differentiation towards 





The menisci are fibrocartilaginous tissues of the knee that are essential in load transmission and 
joint stabilization, properties that are achieved by their unique extracellular matrix (ECM), 
composed of collagenous proteins and proteoglycans. Injuries to the menisci are therefore 
detrimental to the overall mechanical integrity of the joint, and have been implicated in over 
half of all arthroscopic procedures performed by orthopaedic surgeons182. However, the clinical 
outcome of meniscal injuries is dependent on their location. Specifically, tears of the outer 
region can heal, whereas those of the inner region do not. Therefore, tears in the inner region 
are often resected surgically by partial meniscectomy, despite knowledge that even partial 
removal of meniscal tissue directly contributes to osteoarthritis (OA) development in the long-
term127. 
 
The limited extent of innate meniscal repair after injury has led to efforts towards engineered 
tissue repair. Given the contribution of meniscus to weight bearing, and the role of the ECM in 
governing this function, repair tissue must necessarily recapitulate the properties of the native 
ECM. Not only does regional variation in healing exist, but the inner and outer regions of the 
meniscus also differ in ECM composition. The outer region is more fibrous in nature and is 
composed of ~80% type I collagen by dry weight36,37. In contrast, the inner region is more 
cartilaginous, composed of ~40% collagen I and ~30% collagen II by dry weight38. Other 
collagens, such as III, IV, V, and VI, are also present throughout the meniscus to a lesser 
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extent39. The remainder of the tissue is chiefly composed of ~15% proteoglycans, ~2% DNA, 
and other proteins such as adhesion glycoproteins39. Proteoglycans comprise a core protein that 
is covalently bonded to glycosaminoglycans (GAG). In the meniscus, these GAGs include 
chondroitin-6-sulfate (40%) and dermatan sulfate (20-30%)123, sulfated and negatively charged 
polysaccharides that impart the ability to attract water upon the tissue and thereby withstand 
compression. 
 
Recently, promising new approaches have incorporated natural scaffolds made from the ECM 
of decellularized tissues, such as heart183, lung184, and bone185, which preserve native, tissue-
specific molecules that guide the behavior of new cells and facilitate tissue development, 
without the immunogenic components17. Attempts at decellularization of meniscus thus far 
have primarily focused on whole tissue, for application in meniscal replacement. In the 
subpopulation of patients with extensive meniscal damage, but otherwise healthy knee joints, 
meniscal replacement may prove most effective, currently by allograft tissues186, synthetic 
biomaterials12, and in development, decellularized xenografts187–190. However, it has long been 
appreciated that cellular infiltration is significantly confined by the dense meniscus ECM. In a 
canine model, cell repopulation into devitalized meniscal allografts occurred, but the central 
core of the tissue remained acellular even at six months after transplantation191. A 
decellularized whole meniscus was developed previously, but cell migration into the dense 
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tissue was limited to ~150 µm over seven days in vitro, precluding any robust tissue 
formation192. 
 
To overcome this limitation, we created a novel hydrogel from decellularized meniscus ECM, 
supporting the delivery of stem cells for the growth of viable repair tissue. Intra-articular 
delivery of cells has been previously applied in pre-clinical animal193–196 and clinical patient197,198 
studies on osteochondral conditions. However, without an appropriate carrier, a large number 
of cells must be injected to compensate for those that do not survive or are lost from the tissue 
defect196. Therefore, the optimal choice of vehicle to efficiently and effectively deliver cells has 
yet to be ascertained and standardized in practice. We hypothesized that a hydrogel 
comprising decellularized meniscus ECM (mECM) components can provide regulatory cues 
for the formation of new repair tissue. A protocol for decellularization of meniscus and 
processing into hydrogel were developed, in order to deliver mesenchymal stem cells (MSCs) 
into full-thickness defects in meniscal explants. We demonstrate that this mECM hydrogel 
retained meniscus-specific constituents that induce superior fibrochondrogenesis of human 
MSCs compared to collagen I hydrogel alone, and achieve significant tissue integration in an 




5.3. Materials and Methods 
5.3.1. Culture of human mesenchymal stem cells 
Fresh, unprocessed human bone marrow was obtained (Lonza), and human mesenchymal 
stem cells (hMSCs) were isolated and characterized, as previously described185. Cells were 
expanded to passage 5 in basal medium consisting of high glucose (hg) DMEM, 10% fetal 
bovine serum (FBS), 1× antibiotic-antimycotic, and supplemented with 0.1 ng/mL bFGF (Life 
Technologies). 
 
5.3.2. Decellularization and digestion of bovine meniscus ECM 
Juvenile bovine menisci were dissected within 36 h of their slaughter (Green Village Packing 
Company), minced to 1-2 mm3 pieces, and lyophilized for 24 h. Tissue was then decellularized 
at 25°C with agitation in 2% SDS + 10 mM Tris (3 cycles, 24 h each), followed by 0.1% peracetic 
acid (2 h), and washed with sterile water and PBS (3 cycles), before lyophilization again (24 h). 
Decellularized meniscus ECM (mECM) was digested at an initial concentration of 40 mg/mL at 
25°C with agitation in 0.1% pepsin + 0.01 M HCl (12 h), resulting in a mECM digest solution. 
The mECM digests, along with a collagen I control (BD Biosciences) and Precision Plus 
ProteinTM Dual Color Standards (Bio-Rad), were analyzed by SDS PAGE on 4-20% gels (Bio-





5.3.3. Encapsulation of hMSCs in hydrogel 
For hydrogel studies, gelation of the mECM digests and collagen I (rat tail; BD Biosciences) was 
performed, based upon a previously established protocol17. Briefly, mECM (5.61 mg/mL, or x = 
5.61) or collagen I gels (3 mg/mL, or x = 3) were formed by mixing the mECM digest or 
collagen solution (x/10 volume), 0.l N NaOH (x/100 volume), and 10× PBS (x/90 volume) at 4°C. 
The solution was brought to x concentration with hgDMEM containing hMSCs at 30×106 
cells/mL, and injected in 25 µL aliquots into 4 mm Ø poly(dimethylsiloxane) rings. Gelation 
occurred over 40 min at 37°C, and subsequent hMSC-laden constructs in either mECM or 
collagen I hydrogels were cultured for 28 days in chondrogenic media (CM), containing 
hgDMEM, 1× antibiotic-antimycotic, 0.1 μM dexamethasone, 50 μg/mL ascorbate 2-phosphate, 
40 μg/mL L-proline, 100 μg/mL sodium pyruvate, 1× insulin/transferrin/selenium premix (BD 
Biosciences), and supplemented with or without 10 ng/mL TGF-β3 (Peprotech). Samples were 
collected at days 0, 14, and 28 for biochemical, histological, and gene expression analyses. 
 
To characterize the degradation profile of mECM hydrogels, gelation of mECM digests was 
performed as described but without hMSCs, and subsequent acellular constructs were 
cultured for 28 days in CM without TGF-β3 supplementation. Samples were collected at days 
0, 14, and 28 for biochemical and morphological analyses. Additionally, gelation of type I 
collagen and mECM was performed to measure their turbidity, as previously described17. 
Briefly, hydrogels were prepared at 3 mg/mL for collagen I, and 5.61 mg/mL for mECM, and 
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then transferred to a 384-well plate at 40 µL/well. The absorbance of each well was measured at 
405 nm every 2 min for 1 h at 37°C on a SpectraMax spectrophotometer (Molecular Devices). 
These values were used to calculate the time to achieve 50% of the maximum absorbance, 
designated as t1/2. 
 
5.3.4. Culture and mechanical integration testing of meniscal explants 
Juvenile bovine menisci were dissected, as previously described42. Explants were harvested 
from the central tissue region using sterile 4 mm Ø biopsy punches, and cut to 1.5 mm height 
using a custom microtome device. A 1.5 mm Ø central core was punched and removed, 
leaving a tissue ring. Explant rings were devitalized at 4°C with agitation in sterile water (5 
cycles, 24 h each)199. hMSCs were encapsulated in mECM hydrogel as described, and after 3 
days of culture in basal medium, two hMSC-laden mECM gels were press-fitted into the 
devitalized rings.  mECM-explant composites were cultured for 42 days in CM with 10 ng/mL 
TGF-β3. Samples were collected biweekly for mechanical integration testing, biochemical and 
histological analyses. 
 
Briefly, the integration of full-thickness defects in explants was tested with a custom device 
consisting of a 1.33 mm Ø indenter in series with a 50 g load cell, placed above a cup with a 2 
mm Ø hole145. Prior to testing, the height of each sample was measured using a digital caliper. 
The indenter was displaced at a ramp rate of 0.3% of the sample height per second, until the 
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central core was pushed fully through the outer ring. Integration strength was calculated as the 
ratio of the peak force to the surface area of contact between the central core and outer ring.  
 
5.3.5. Subcutaneous implantation in nude mice 
After 6 weeks of in vitro culture, devitalized meniscal explants containing mECM-encapsulated 
hMSCs were implanted subcutaneously into nude mice for 4 weeks in vivo, according to an 
approved IRB protocol at Columbia University. Briefly, NOD.SCID mice (Harlan) were 
anesthesized by intraperitoneal injections of ketamine (80-100 mg/kg) and xylazine (5-10 
mg/kg), and by subcutaneous administration of buprenorphine SR (1.2 mg/kg). Constructs 
were implanted into separate subcutaneous dorsal pockets (1 construct per pocket, 2 pockets 
per animal). Two hours prior to sacrifice, animals were injected with 5-bromo-2-deoxyuridine 
(BrdU, Invitrogen; 1 mL/100 g, intraperitoneal) to assess cellular proliferation. Implants were 
collected after 4 weeks in vivo and evaluated for expression of chondrogenic, hypertrophic, and 
osteogenic markers. 
 
5.3.6. Gene expression of hMSCs 
Total RNA of hMSC-laden mECM or collagen gels at days 0, 14, 28 were extracted by TRIzol 
reagent (Invitrogen) and reverse transcribed (High Capacity cDNA Reverse Transcription Kit; 
Applied Biosystems). Subsequent cDNA amplification was performed using an Applied 
Biosystems StepOnePlus Real-Time PCR System, Fast SYBR Green Master Mix (Invitrogen), 
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and custom human primers for ACAN, COL1A2, COL2A1, COL10A1, and GAPDH to calculate 
relative expression (2-ΔCT). 
 
5.3.7. Biochemical content of hydrogel-encapsulated cells 
The biochemical content of native and decellularized mECM, mECM digests, and mECM- and 
collagen-encapsulated hMSCs was quantified by DNA, sulfated GAG, and collagen assays. 
Briefly, samples were lyophilized for 24 h and digested at 60°C for 16 h in a papain solution 
containing 125 µg/mL papain (Sigma-Aldrich), 50 mmol phosphate buffer (pH 6.5), and 2 
mmol N-acetyl cysteine (Sigma-Aldrich). The DNA content of sample digests was obtained 
using the PicoGreen dsDNA quantitation kit (Invitrogen), according to manufacturer’s 
protocol. Sulfated GAG content was measured using the 1,9-dimethylmethylene blue dye-
binding assay167. Collagen  content was quantified by a modified acid hydrolysis assay168, using 
hydroxyproline as standards for meniscus ECM and hMSC-laden gels, or collagen I solution 
for mECM digests. 
 
5.3.8. Histological analysis 
For histological processing, hydrogel-encapsulated hMSCs were embedded in 2% low-
melting-temperature agarose and fixed at 4°C in 4% formaldehyde. All samples were then 
dehydrated in a graded series of ethanol, embedded in paraffin, and sectioned to 8 μm 
thickness. Sections were stained with hematoxylin and eosin for nuclei and cytoplasmic 
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elements, respectively, Alcian blue (pH 1.0) for sulfated GAGs, and Picrosirius red for 
collagens. Additionally, implanted samples were stained with von Kossa for mineralization. 
 
For immunohistochemistry, the following primary antibodies were used for hMSCs in 
hydrogels: mouse anti-collagen I (1:200; Abcam); rabbit anti-collagen II (1:50; Abcam); mouse 
anti-collagen X (1:2000; Abcam); rabbit anti-N-cadherin (1:50; Santa Cruz Biotechnology); and 
mouse anti-human nuclei (1:50; Millipore). Briefly, all samples were processed using the 
VECTASTAIN Elite ABC Kit (Universal; Vector Laboratories) and counterstained with 
hematoxylin QS, with the exception of staining against human nuclei. BrdU was detected in 
implanted samples, according to manufacturer’s protocol (BrdU staining kit, Invitrogen). 
Antigen retrieval was performed in 10 mM citrate buffer (pH 6.0; anti-human nuclei, N-
cadherin), 0.5% trypsin (anti-collagens I, II), or a combination of hyaluronidase and pronase 
(anti-collagen X)200. All stained specimens were imaged with an Olympus FSX100 microscope. 
 
5.3.9. Statistical analysis 
Unpaired t-tests for decellularization and t1/2, 1-way ANOVA with Tukey post-hoc tests for 
degradation and explant studies, and 2-way ANOVA with Bonferroni post-hoc tests for 





5.4.1. Decellularization caused significant loss of intracellular material, but preserved extracellular 
sulfated GAG and collagen content 
Meniscus tissue decellularization produced a significant decrease in DNA content (Figure 
5.1a), and a corresponding loss in visible cell nuclei upon H&E staining (Figure 5.1b). In 
contrast, no significant changes in sulfated GAG or hydroxyproline (OHP) content were 
detected between native and decellularized tissue, and likewise, no discernible changes in the 
intensity of staining were demonstrated by Alcian blue and Picrosirius red staining for sulfated 
GAG and collagen, respectively. Taken together, maximizing the loss of nuclear content while 






Figure 5.1. Decellularization of meniscus. 
(a) Biochemical content of meniscus before (native) and after decellularization (decellularized). DNA content 
was significantly reduced by the decellularization process, but sulfated GAG and hydroxyproline (OHP), 
indicative of collagen, were not. * p < 0.05 vs. native; n = 7-32. (b) Histological staining of meniscus before and 
after decellularization for cell nuclei (H&E), sulfated GAG (Alcian blue), and collagen (Picrosirius red). The 
presence of cell nuclei in native tissue was lost after decellularization, whereas changes in the staining 
intensity for sulfated GAG and collagen were not appreciable. Scale bar: 100 µm. 
 
5.4.2. Collagen I and other meniscus ECM components were extracted by pepsin digestion  
Meniscus ECM was further extracted by pepsin digestion of decellularized tissue, yielding a 
viscous, opaque solution consisting of 0.92 ± 0.10 µg/mL DNA, 22.32 ± 6.70 µg/mL sulfated 
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GAG, and 7.34 ± 0.66 mg/mL collagen (n = 5). Pepsin digestion of the tissue was not complete, 
as only one-third of the collagen in bovine menisci at most was previously reported to be 
pepsin-soluble37, which most likely contributed to the lower yield of collagen in the pepsin 
digest. Therefore, despite the maintenance of sulfated GAG and collagen levels after 
decellularization, pepsin extraction varied the composition of the mECM digest. Nevertheless, 
when comparing the mECM digests to collagen I alone, the presence of multiple additional 
bands on SDS PAGE analysis suggests that other meniscus ECM components were indeed 
liberated by pepsin digestion (Figure 5.2a). 
 
The retention of GAG in the mECM digests can be further visualized by the patterns of 
collagen fibrillogenesis between collagen I and mECM (Figure 5.2b). Turbidimetric gelation 
kinetics of mECM were dramatically slower than collagen I, as well as achieving a lower 
maximum absorbance. Specifically, the t1/2, or the time required to reach 50% of the maximum 
absorbance, was 6.82 ± 0.24 min for collagen I, and 18.20 ± 1.16 min for mECM (p < 0.05; n = 6-
12). The lag in time for gelation of mECM suggests a lower proportion of collagen I, which can 
be expected, given that the meniscus ECM contains both types I and II collagen, but also the 




Figure 5.2. Comparison of decellularized meniscus ECM (mECM) and type I collagen. 
(a) SDS PAGE of mECM digests versus type I collagen. Pepsin digests of decellularized meniscus ECM 
demonstrated the presence of multiple bands in addition to the three seen in collagen I after denaturation. 
These additional bands represent other mECM components that were retained after decellularization and were 
soluble in pepsin. (b) Turbidimetric gelation kinetics of type I collagen (3 mg/mL) and mECM (5.61 mg/mL). 
Representative curves for absolute and normalized absorbance at 405 nm. Collagen I gelation occurs more 
rapidly and with greater associated turbidity than mECM. 
 
5.4.3. Acellular mECM hydrogels depleted their collagen content in vitro 
In the absence of cells, mECM hydrogels exhibited significant loss of collagen within the first 
two weeks of culture (Figure 5.3b), consistent with a perceivable decrease in size over time 
(Figure 5.3a). Likewise, residual DNA content in the hydrogels decreased rapidly. Sulfated 
GAG content of the hydrogels did not significantly decrease over 28 days of culture. However, 




Figure 5.3. In vitro degradation of acellular mECM hydrogels. 
(a) Gross morphology of acellular mECM hydrogels. Over 28 days in vitro, acellular hydrogels degraded and 
decreased in size. (b) Biochemical content of acellular mECM hydrogels. DNA and OHP content significantly 
decreased over 28 days in vitro, but sulfated GAG content did not vary. * p < 0.05 vs. days 14, 28; ** p < 0.05 
vs. day 28; n = 4-5. 
 
5.4.4. Fibrochondrogenesis of hMSCs was superior in mECM hydrogel compared to collagen I alone, but 
requires growth factor supplementation 
In the presence of TGF-β3, encapsulation of hMSCs in mECM hydrogel (mECM +) led to 
enhanced fibrochondrogenesis, compared to cells in collagen I alone (collagen +; Figure 5.4a). 
DNA content in collagen gels (+) decreased throughout the 28-day culture period, while the 
DNA content of mECM gels (+) initially fell between days 0 and 14, but was then maintained 
from days 14 to 28. Sulfated GAG and OHP content were both significantly higher in mECM 
constructs than in collagen at day 28. The OHP content of collagen constructs decreased 
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throughout the culture period, in contrast to mECM constructs, in which it recovered 
significantly between days 14 and 28. 
 
In the absence of TGF-β3, neither mECM (–) nor collagen I (–) hydrogels significantly 
supported fibrochondrogenesis of hMSCs (Figure 5.4a), with general decreases in cell numbers 
and OHP content for both hydrogels, and a lack of sulfated GAG production. Previously, 
cartilage-derived ECM scaffolds were found to be  capable of inducing differentiation in the 
absence of exogenous growth factors202. In contrast, our findings suggest that after 
decellularization and digestion, the resulting hydrogel does not retain intact or active growth 
factors that can self-motivate fibrochondrogenesis. Nevertheless, the superior 
fibrochondrogenesis of hMSCs in mECM hydrogel with TGF-β3 does suggest that the 
components remaining in mECM hydrogel were sufficient to drive fibrochondrogenesis, 
compared to collagen I alone. 
 
Histological staining of constructs cultured with TGF-β3 was consistent with biochemical 
content, demonstrating the production of a sulfated GAG-rich matrix (Alcian blue; Figure 5.4b) 
and stronger staining for collagens (Picrosirius red) in mECM constructs. Cells in mECM 
hydrogel (+) were situated within well-developed lacunae (H&E) that were not present in 





Figure 5.4. Fibrochondrogenesis of hMSCs in mECM versus collagen hydrogels. 
(a) Culture of hMSCs in mECM and collagen I hydrogels, with (+) and without (–) 10 ng/mL TGF-β3. Although 
hMSCs did not differentiate in either hydrogel in the absence of TGF-β3, the cells produced significant matrix in 
mECM hydrogel with TGF-β3 supplementation. * p < 0.05 vs. day 0; ** p < 0.05 vs. day 14 collagen –, collagen 
+; *** p < 0.05 vs. day 28 collagen +, mECM –; n = 3-10. (b) Histological staining of mECM and collagen I 
constructs with TGF-β3 supplementation. hMSCs in mECM hydrogel were arranged in lacunae surrounded by 
matrix rich in sulfated GAG and collagens, compared to cells in collagen hydrogel. Scale bar: 50 µm. 
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Furthermore, expression of key meniscus ECM genes, aggrecan (ACAN), the predominant 
proteoglycan in meniscus, and collagen II (COL2A1; Figure 5.5a), was significantly 
upregulated in hMSC-laden mECM gels with TGF-β3 at day 28 compared to initial values. 
However, though collagen I gene expression increases in mECM gels, its expression in collagen 
gels exceeds that of mECM gels at day 28. Expression of collagen X, a marker of hypertrophy, 
increases with construct maturity in both hydrogels, but is significantly greater at day 28 in 
collagen hydrogels only, not in mECM. 
 
Translation of these gene expression patterns to the protein level revealed significant positive 
staining for collagen II in both hMSC-mECM and collagen constructs at day 28 (Figure 5.5b). 
Collagen I staining was present throughout collagen constructs at day 28, but appear limited to 
the mECM construct edge and inside the cell lacunae, rather than secreted into the newly 
synthesized ECM. Positive staining for collagen X appeared in both collagen and mECM 
constructs, with intracellular staining in collagen constructs, indicative of sustained production, 
that is not seen in mECM. At day 0, faint but positive staining for collagen I appears in both 
constructs, consistent with collagen I as the basis for gelation of both materials. However, only 
mECM exhibited positive collagen II staining, due to its presence in the native mensicus ECM. 
Finally, no visible staining for collagen X appeared in either hydrogel at day 0, signifying an 





Figure 5.5. Expression of specific meniscus ECM components in hMSC constructs. 
(a) Relative gene expression (2-ΔCT) of hMSCs encapsulated in collagen I or mECM hydrogels, over 28 days of 
culture with TGF-β3 supplementation. Expression of aggrecan (ACAN) and collagen II (COL2A1) were 
significantly greater at day 28 in mECM constructs, whereas collagen I (COL1A2) and X (COL10A1) were 
significantly greater at day 28 in collagen constructs. ACAN: * p < 0.05 vs. mECM days 0, 14; n = 4. COL2A1: * 
p < 0.05 vs. mECM days 0, 14, collagen day 28; n = 4. COL1A2: * p < 0.05 vs. collagen days 0, 14, mECM day 
28; n = 4. COL10A1: * p < 0.05 vs. collagen day 0; n = 4. (b) Immunohistochemistry of hMSC-mECM and 
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collagen constructs. Significant staining for collagen II appears at day 28 in both constructs, but only mECM 
hydrogel contained collagen II initially. Positive staining for collagen I is present in both collagen and mECM 
constructs at day 0, but staining is more prevalent at day 28 throughout collagen constructs. Collagen X does 
not appear in either hydrogel at day 0, but develops by day 28, although positive staining is present both intra- 
and extracellularly in collagen constructs compared to mECM. Scale bar: 50 µm. 
 
5.4.5. hMSCs delivered in mECM hydrogel significantly enhanced integrative repair of meniscal 
explants 
mECM hydrogel delivery of hMSCs into full-thickness defects in meniscal explants 
significantly enhanced the mechanical and biochemical properties of repair tissue over 42 days 
(Figure 5.6a), with increases in biochemical content that were consistent with the trends 
observed in hydrogel studies. H&E staining revealed the organization of cells separated by 
newly synthesized ECM, rich in sulfated GAG (Alcian blue) and collagens (Picrosirius red; 
Figure 5.6b). In particular, the development of cell lacunae was prominent at the defect 
interface. 
 
After six weeks in vitro, hMSC-mECM explants were implanted subcutaneously for an 
additional four weeks in vivo. Constructs at day 70 exhibited variable staining for 
mineralization, ranging from negative (von Kossa –; Figure 5.7a) to moderate deposits (von 
Kossa +). In both positive and negative mineralization samples, well-developed lacunae were 
now present throughout the constructs (Figure 5.6b), with no discernible differences in 




Figure 5.6. hMSCs delivered in mECM hydrogel adhere to full-thickness defects in meniscal explants. 
(a) Integration strength and biochemical content of hMSC-mECM explants over six weeks in vitro. The 
development of integration strength correlated with significant production of sulfated GAG and collagen. 
Integration strength: * p < 0.05 vs. days 0, 14; n = 3-8. DNA, GAG, OHP: * p < 0.05 vs. days 0, 28, 42; ** p < 
0.05 vs. days 0, 14; *** p < 0.05 vs. days 0, 14, 28; n = 3-8. (b) Representative images of explants before and 
after four weeks of in vivo implantation, with (von Kossa +) and without (von Kossa –) mineralization. In both 
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mineralized and non-mineralized explants, well-developed lacunae appear throughout the sample, whereas 
those before implantation are confined at the defect interface, indicated by arrows. Scale bar: 50 µm. 
 
5.4.6. Stability of fibrochondrogenic hMSCs in mECM hydrogel varied in vivo 
After four weeks in vivo, constructs varied in their state of mineralization, from no detection of 
phosphate deposits by von Kossa staining (von Kossa –; Figure 5.7) to moderate (von Kossa +). 
Immunohistochemistry specific for human nuclei verified the cell source within the explant, 
and confirmed them to be of human origin. BrdU, a marker of proliferating cells, demonstrated 
positive staining that was concentrated along the hMSC-explant interface, suggesting 





Figure 5.7. Representative images of hMSC-mECM explants after in vivo implantation. 
hMSC-mECM explants demonstrated variable staining for mineralization, from negative (von Kossa –) to 
moderate (von Kossa +). Immunohistochemistry against human nuclei confirmed hMSC identity within the 
explant, and against BrdU for proliferating cells, which were concentrated along the defect interface, indicated 
by arrows. Scale bar: 50 µm. 
 
In order to discern the composition of hMSC-mECM explants, collagen I, II, and X 
immunohistochemistry was performed (Figure 5.8). Collagen II staining was uniform 
throughout the mECM gel before implantation, with localized staining at the periphery of cell 
lacunae in the pericellular matrix. After implantation, this staining remained uniform within 
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the constructs. In contrast, collagen I staining before implantation was confined to within the 
pericellular matrix, whereas the matrix uniformly stained for collagen I after in vivo culture. 
Collagen X staining was minimal before implantation, and curiously, despite the presence of 
mineralization, neither von Kossa-positive nor negative constructs exhibited significant 
staining for collagen X, a primary marker of hypertrophy. 
 
 
Figure 5.8. Expression of fibrochondrogenic and hypertrophic markers before and after in vivo implantation. 
Before in vivo implantation, hMSC-mECM explants exhibited significant staining for collagen II, but not collagen 
I or X. After four weeks of implantation, both mineralized and non-mineralized explants were collagen II- and I-




A meniscus ECM-derived hydrogel scaffold provided the foundation for engineering repair 
tissue. Hydrogel composed of decellularized meniscus ECM retained characteristic elements of 
the native tissue that guided the fibrochondrogenesis of hMSCs. Although type I collagen 
comprises a significant portion of the meniscus ECM, culture of hMSCs in mECM hydrogel 
exhibited cell growth, sulfated GAG and collagen production superior to cells in collagen I 
alone, demonstrating the importance of other mECM components.  
 
We have determined that our mECM hydrogel contains types I and II collagen, reminiscent of 
native meniscus, but not collagen X, associated with hypertrophy. Given that only a third of 
the collagen present in bovine meniscus is pepsin-soluble37, we must consider that other 
meniscus ECM components may not be liberated into solution as a result of entrapment in the 
dense collagenous matrix, and are therefore not present in our hydrogel recapitulation of the 
native meniscal environment. Among these include the fraction of pepsin-resistant collagen, 
sulfated GAGs, as well as growth factors that were present natively in the meniscus. Recently, 
endogenous cartilage-derived matrix proteins retained in an articular cartilage ECM-based 
scaffold were implicated as the regulators of functional chondrogenesis in adipose-derived 
stem cells, without exogenous growth factors in culture202. In their study, the articular cartilage 
ECM was simply devitalized by freezing, which may account for the retention of intact 
chondrogenic growth factors within the scaffold. In contrast, our study subjected tissue to 
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chemical decellularization to remove immunogenic cells, which likely led to the inactivation or 
loss of these endogenous tissue growth factors, and the subsequent need for exogenous 
supplementation to induce fibrochondrogenesis. Nevertheless, we demonstrate that the ECM 
components retained after decellularization, digestion, and gelation, in concert with TGF-β3, 
stimulated hMSC behavior to a degree that was not achieved by the combination of collagen I 
and TGF-β3 alone. The derivation of “matrikine” species via the partial proteolysis of ECM 
proteins, which in turn regulate cell activity, may account for this marked difference in tissue 
formation between mECM and collagen hydrogel. Moreover, even in defined, bio-inspired 
materials containing specific molecules known to direct differentiation, chondrogenesis of 
hMSCs required the addition of TGF-β3 for complete effect203. 
 
While the decellularization process preserved sulfated GAG content at near-native levels, 
detection of sulfated GAGs by assay or staining was dramatically lower after pepsin extraction 
and reconstitution into hydrogel. Collagen fibrillogenesis is characterized by two stages, a 
nucleation phase, followed by a fiber growth phase204. The addition of GAGs during the 
nucleation or fiber growth phases can accelerate or inhibit collagen fiber formation201. The 
differences observed between the fibrillogenesis of type I collagen only and mECM suggest the 
persistence of GAGs in the pepsin digest, despite the results of the sulfated GAG assay and 
Alcian blue staining, which seem to imply otherwise. It is known that pepsin degrades 
cartilage proteoglycans, and produces fragments of larger size than papain, a proteinase which 
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cleaves between each GAG chain205. Papain is routinely used with success, in our current study 
as well as many prior, to digest fibrocartilaginous tissues for sulfated GAG analysis. This 
apparent discrepancy between papain digestion of tissues to assay sulfated GAG, and pepsin 
digestion of mECM which did not yield significant sulfated GAG, suggests two possibilities: 
much of the sulfated GAG remains in the pepsin-resistant fraction of mECM and was not 
solubilized, or pepsin may have altered the sulfated GAGs such that they were no longer 
detectable by conventional methods. Given the altered fibrillogenesis profile of mECM 
hydrogel from the norm, it is most likely a combination of both: a significant portion remained 
in the dense, pepsin-resistant collagenous matrix, while the pepsin-soluble sulfated GAGs 
were chemically altered. Nevertheless, fibrochondrogenesis of hMSCs in mECM gel with TGF-
β3 led to significant sulfated GAG production, despite its perceived absence initially in the 
hydrogel. 
 
The presence of residual DNA in the decellularized meniscus ECM hydrogel is of concern for 
its future clinical application. Optimization of our decellularization parameters required a 
balance of minimizing DNA content while simultaneously minimizing the degradation of 
collagen I that would prevent repolymerization. We tested a variety of protocols, including one 
which achieved >98% decellularization using SDS, trypsin, and a higher concentration of 
peracetic acid over a longer time period, but also caused irreversible chemical changes to the 
type I collagen remaining in the decellularized tissue, inhibiting its gelation. Moreover, it 
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should be noted that, to the best of our knowledge, of all currently published studies on 
meniscus decellularization187–190,206,207, only one has reported the quantitative DNA content 
remaining in their tissues after processing187, with the rest relying instead on histological 
assessment of cell nuclei loss. In this particular study, decellularization of porcine menisci 
occurred on the order of weeks, and resulted in a 95% decrease in DNA by wet weight, based 
upon DNA absorbance peaks in spectrophotometry. Given the difference in application 
between their decellularized meniscus for transplantation and our hydrogel, a direct 
comparison between the two methods is not wholly practical. However, our procedure can be 
performed within five days, resulting in an overall decrease in DNA content per dry weight of 
>74%, then stored in its lyophilized state before pepsin digestion for an additional 16 h. In our 
studies, we opted to strike a balance between removing DNA content and retaining the 
integrity of type I collagen to enable gelation. Ultimately, for the delivery of stem cells in a 
clinical setting, it may be desirable to completely decellularize the meniscus ECM, at the 
expense of the intrinsic type I collagen, then mix with a commercially prepared collagen I 
solution for in situ polymerization.  
 
Discussion of our ECM-derived hydrogel naturally brings up comparisons to platelet-rich 
plasma (PRP), a platelet concentrate obtained from blood plasma. Recently, PRP has seen 
prevalence in the treatment of orthopaedic injuries and OA208,209, often as a carrier for 
mesenchymal stem cells210–212. Like ECM-based scaffolds, the precise composition of PRP is not 
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known, but TGF-β, platelet-derived growth factor, and insulin-like growth factor are among 
the growth factors present in the isolate213, all of which have been previously studied in the 
context of meniscus153,214,215. However, given that PRP is extracted autologously per donor, it is 
widely acknowledged that the quality of PRP varies from donor to donor216,217. Curiously, there 
were no significant correlations demonstrated between gender or age of the donor and the 
concentration of growth factors in their PRP218. This shortcoming has brought the general 
efficacy of PRP into question. In contrast, we report the first instance of a hydrogel preparation 
of decellularized meniscus ECM that can easily be manipulated for directed delivery of stem 
cells for meniscal repair. Decellularized ECM could be processed in large batches across 
multiple donors, decreasing the variability from donor to donor, and stored until ready for use. 
In our protocol, we did not specifically isolate the native tissue by region, and pooled ECM 
from both the inner and outer zones, which are known to differ natively. Our resulting 
hydrogel contained both collagens I and II, representative of the inner region, which does not 
normally heal. However, future extraction of meniscus ECM specific to the inner zone may 
further efforts to engineer repair of injuries to this region. 
 
The enhanced fibrochondrogenesis of hMSCs observed in mECM gel suggested its utility for 
delivery of MSCs into full-thickness defects in meniscal explants for integrative repair. hMSCs 
delivered in mECM hydrogel adhered to meniscal defects and elaborated extensive 
fibrocartilaginous matrix, culminating in significant integrative repair in vitro. However, 
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hMSC-mECM explants exhibited variable stability of fibrochondrogenic phenotype after an 
additional four weeks of implantation in vivo. There has been much speculation on if current 
protocols for chondrogenesis of MSCs can truly form cartilage as an end point. Hypertrophy 
and evidence of terminal differentiation to bone in MSCs has been reported extensively both in 
vitro and in vivo219–221. In the context of meniscus, collagen X protein has been detected in both 
normal and OA tissue, with increased expression in aged and degenerative OA menisci222,223 
that generally correlated with calcification in vivo224,225. This co-localization of collagen X and 
mineralization was not observed in our studies. However, it is likely that our choice of a single 
endpoint simply missed any increases in collagen X expression that preceded mineralization.  
 
Given the human identity of cells within the explant, the cells that produced mineralization are 
likely also human, and arose from the initial cells encapsulated in mECM. Whether these 
osteogenic cells derive from undifferentiated cells remaining after in vitro culture, 
dedifferentiation of chondrogenic MSCs and subsequent redifferentiation into the osteogenic 
lineage, or transdifferentiation from chondrogenic MSCs directly to osteogenic remains 
unclear226. Above all, these findings call into question the validity of the highly vascularized 
subcutaneous environment for study of predominantly avascular tissues. It is known that the 
combination of MSCs with native meniscal cells prevents MSC hypertrophy227,228, and that the 
meniscus itself contains a subpopulation of endogenous repair cells42 which can interact with 
and influence the behavior of exogenously delivered MSCs. To this end, a rat model of 
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meniscal repair is currently in development for evaluation of the mECM hydrogel as a vehicle 
for intra-articular delivery of MSCs. By testing the material for its ability to entrap cells and 
provide a fibrochondrogenic environment in its native anatomic location, we can better 
understand its capacity to regulate hMSC differentiation and maintain fibrocartilage stability. 
 
In summary, decellularized meniscus ECM hydrogel provides a foundation for stem cell-based 
repair, via preservation and presentation of biological cues from the native tissue environment 
that stimulate cell growth and synthesis of new ECM by hMSCs in vitro. However, further 
characterization of mECM hydrogel in situ is necessary in order to gain insight into its potential 





Chapter 6. Summary and future directions 
6.1. Summary 
The removal of damaged meniscal tissue by meniscectomy has been in practice for over a 
century229. Although repair has since been recognized as the first-line option in the treatment of 
meniscal tears, the complex anatomy and properties of the tissue often preclude the success of 
such operations. Indeed, arthroscopic partial meniscectomy has been listed as the most 
commonly performed procedure by survey of orthopaedic surgeons, at twice the frequency of 
the next procedure on the list159. These limitations represent an opportunity for scientists and 
clinicians to develop improved methods for meniscal repair, as preservation of meniscal tissue 
and function offers a chance to prevent further osteoarthritic degeneration within the knee joint 
and improve quality of life. 
 
In this dissertation, we share our findings on three methods that can enhance the native 
healing properties of the meniscus. In chapter 3, we studied the direct role of vasculature on 
meniscus cell migration and tissue repair. We hypothesized that vascular endothelial cells 
regulate meniscus cell migration, and that behavior between cells from the inner and outer 
regions may vary due to native differences in vascularity. However, we discovered that 
meniscal fibrochondrocytes, isolated by outgrowth from juvenile bovine tissue, exhibited 
similar patterns in migration when cultured with human umbilical vein endothelial cells in a 
three-dimensional micropatterned hydrogel system. The micro-scale migration assay enabled 
116 
 
us to vary culture parameters and investigate the paracrine mechanisms by which HUVECs 
influenced migration of bovine MFCs. We identified endothelin-1 as a novel angiogenic factor, 
previously unstudied in the meniscus, which enhances migration of both inner and outer 
bMFCs. In order to confirm that our micro-scale cellular findings were also applicable at the 
tissue macro-scale, we supplemented endothelin-1 to a meniscal explant model of a full-
thickness defect. We report that endothelin-1 enhances the proliferation of juvenile bMFCs in 
explants, and the migration of cells towards integrative repair. 
 
In chapter 4, we analyzed the effects of pulsatile direct current electric fields on meniscus cell 
migration and tissue repair. We hypothesized that EFs can control the migration of meniscus 
cells from both the inner region of the meniscus, which normally does not heal, and the outer 
region, which does. By combining the micropatterned migration assay with a custom 
bioreactor for electrical stimulation, we created a system to characterize the three-dimensional 
migration behavior of inner and outer bMFCs in EFs and optimized these parameters for 
translation to the macro-scale. We validated electrical stimulation regimes for cell migration on 
the micro-scale that were applicable to the macro-scale, as demonstrated by superior 
integrative repair of full-thickness defects in meniscal explants. We proposed a role for 
adenosine A2b receptor in relaying electrical signals to meniscus cells, stimulating tissue repair 




Finally, in chapter 5, we detail our work on developing a hydrogel scaffold derived from the 
meniscus extracellular matrix for application to tissue repair. We hypothesized that the unique 
ECM, which imparts the meniscus with its biomechanical properties, can also provide cues 
towards formation of new repair tissue by mesenchymal stem cells, after decellularization to 
remove immunogenic components and preparation into hydrogel form. Our decellularized 
meniscus ECM hydrogel retained native ECM components other than collagen I that directed 
fibrochondrogenesis of hMSCs, superior to a hydrogel of collagen I alone. mECM hydrogel 
delivery of hMSCs adhered to full-thickness defects in meniscal explants and produced 
significant new ECM for integrative tissue repair. 
 
6.2. Limitations and future directions 
Our studies in meniscus are among the first of their kind to demonstrate the effects of vascular, 
electrical, and matrix-derived signals on cell migration and tissue repair. For all studies, the 
choice of model is paramount, as one’s findings are only as reliable as one’s model. To this end, 
we consistently used only three-dimensional models230, in hydrogels or explants, as the 
behavior of both fibrochondrocytes and fibrochondrogenic MSCs varies significantly from 2-D 
to 3-D. Although we utilized a simplified micropatterned system of hydrogel-encapsulated 
cells for migration, it served as a means of screening a broad range of parameters before 
verifying their efficacy at the macro-explant level. However, all of these studies were 
performed using cells or explants from juvenile bovine menisci, which are commonly used in 
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literature42,117,121,153,170,231, but nevertheless represent both an interspecies and age difference from 
clinical patients. Even the integration potential of adult bovine meniscus is known to be far 
below that of fetal and juvenile tissue121. Therefore, the effects of endothelin-1 and electrical 
stimulation on migration must be validated using adult bMFCs at least, and preferably, human 
cells derived from surgical debris. Along these lines, our experiments involved the use of only 
one human donor for MSCs, whereas donor-to-donor variability is a relevant concern and 
necessitates further study with additional donors.  
 
Furthermore, our findings must be validated under in vivo conditions. To this end, the choice of 
appropriate in vivo environment is imperative. When we transitioned our mECM hydrogel 
from in vitro culture to in vivo implantation, the highly vascularized subcutaneous environment 
may have directly contributed to the osteogenic changes in our hMSC-derived fibrocartilage. 
Therefore, we are developing a model of in vivo meniscal repair in rat, the smallest animal 
previously utilized in meniscus literature196,232–234, in order to confirm the phenotypic stability of 
hMSCs delivered by our mECM hydrogel in situ. The rat is a suitable model for preliminary 
animal studies, as it is relatively inexpensive, enabling larger sampling sizes, and meaningful 
results can be obtained within weeks rather than months for larger animals. However, the rat 
meniscus is also known to vary biochemically and morphologically from the human 
meniscus235, and therefore can only serve as the entry level model for study of meniscal repair 
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in vivo. Larger animals such as the sheep are more suitable pre-clinical models for eventual 
clinical translation. 
 
Our studies into meniscal repair all operate on the assumption that intervention will prevent or 
delay the onset of osteoarthritis in the knee. Therefore, it will be necessary to test the effects of 
endothelin-1, electrical stimulation, and MSC delivery on the surrounding articular cartilage. 
Although MSCs do not appear to mobilize outside the knee joint, there is evidence that in 
addition to meniscal repair, they offer chondroprotection in a variety of animal models196,232–
234,236–238, by directly interacting with the native cartilage or indirectly by meniscal regeneration. 
Furthermore, although ours is only the second report of the application of electrical signals to 
meniscus, our work has benefited from previous insight gained through numerous studies on 
electrical stimulation of cartilage90,93–95,105,113,239–245. However, endothelin-1 has been implicated in 
the pathogenesis of osteoarthritis154,155, and it will be of interest to determine its effects on 
normal articular cartilage before degeneration. 
 
In consideration of treatments for meniscal damage, we must also include the potential of total 
meniscal replacement, by allograft, synthetic, or decellularized tissues. Allograft tissue has been 
limited by donor availability, corresponding anatomic suitability, and the usual concerns 
related to transplantation246. Synthetic replacements can be produced en masse commercially, 
but the unique and intricate relationship between meniscal structure and function has proven 
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to be a challenge in itself to recapture247. Decellularized tissue replacements hold great promise, 
although significant interaction with endogenous MFCs or exogenous stem cells will prove 
difficult, given the density of the meniscus ECM192. Although this dissertation does not 
specifically focus on engineered tissue replacements, the methods developed for repair are 
applicable as adjuvant or combination therapies to overcome limitations in the use of tissue 
replacements. Angiogenic supplementation and electrical stimulation for enhanced cellular 
infiltration can further enhance integration between the graft and native tissue. Decellularized 
meniscus ECM hydrogel can also be used to deliver cells within the graft. Although we studied 
these factors in the context of a specific repair model, they are relevant in the treatment of a 
broader range of meniscal lesions in concert with other techniques. 
 
Additionally, in this dissertation, we did not consider the direct contribution of mechanical 
stimuli to meniscal repair and regeneration50,53,54,248–253. Given the complex biomechanical 
capacity of the meniscus, dynamic application of tensile, compressive, or shear forces can be 
optimized for synergy with endothelin-1 or ECM-derived signals. Immobilization has been 
shown to prevent the otherwise increase in blood flow to injured menisci in a rabbit model254, 
so dynamic loading may reinforce the effects of angiogenic factors involved in the vascular 
response of the meniscus. Moreover, tensile loading in a bioreactor system has demonstrated 
great efficacy in maturation of tissues generated from mesenchymal stem cells251. Finally, 
electrical and mechanical stimuli can be applied in concert to injured tissues, in order to 
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amplify downstream events that normally occur in response to mechanical stimuli, but are 
diminished after injury. 
 
Finally, although each of the factors studied, vascular, electrical, and matrix-derived, have 
relevance in the development of significant integrative meniscal repair, we did not investigate 
their combined action together. Advances in therapeutic strategies for meniscal injuries require 
the integration of chemical, physical, and environmental factors governing cell migration and 
repair. While this dissertation focused on decoupling their individual contributions, we expect 
that vasculature, electrical stimulation, and matrix constituents can jointly contribute to 
meniscus cell migration and tissue repair, both in the laboratory and clinical settings. 
 
6.3. Conclusions 
In closing, interest and subsequent study in meniscal repair has progressed rapidly with 
increasing rigor over the past decade. We believe our work on the role of vascular, electrical, 
and matrix-derived signals has revealed insight into three aspects of meniscal repair that have 
previously seen limited in-depth study, and contributes to a growing fund of knowledge 
regarding a complex and previously misunderstood tissue. Furthermore, we expect that the 
interplay of chemical factors (via vasculature), physical forces (via EFs), and components of the 
native tissue environment (via mECM) can stimulate cell migration and enhance meniscus 
repair. By challenging the field to not only demonstrate significant results with growth factor 
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supplementation, mechanical stimulation, or biomaterial design, but also investigate the 
mechanisms that underlie and govern these changes, we move towards a strong scientific basis 
for advances in clinical strategies for meniscal repair and regeneration, and towards a better 
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